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Heat and mass transfer analysis has its application in various fields including 
automobile, steam-electric power generation, energy systems, HVAC, electronic device 
cooling and in characterizing and diagnosing diseases. Here we have focused on applying 
the principles of heat and mass transfer to biological tissue and materials.  
In the first part we introduce a computational method to simultaneously estimate 
size, location and blood perfusion of model cancerous breast lesions from surface 
temperature data. A 2-dimensional computational phantom of axisymmetric tumorous 
breast with six tissue layers, epidermis, papillary dermis, reticular dermis, fat, gland, 
muscle layer and spherical tumor was used to generate surface temperature distributions 
and estimate tumor characteristics iteratively using an inverse algorithm based on the 
Levenberg-Marquardt method. However, similar steady state temperature profiles for 
different tumors are insufficient  to simultaneously estimate blood perfusion, size and 
location of tumor. This becomes possible when transient temperature data are used along 
with steady state data. Thus, in addition to the steady state temperature data, we modified 
and expanded the inverse algorithm to include transient data that can be captured by 
dynamic infrared imaging. Blood perfusion is an indicator of the growth rate of the tumor 
and therefore its evaluation can lead to assessment of tumor malignancy. 
In the second part we treat X-ray computed tomography (CT) perfusion. The goal 
was to reduce the total radiation exposure by reducing the number of scans without 
compromising information integrity. CT scan images obtained from a rabbit model of 
liver and tumors were processed using the maximum slope (MS) method to estimate 
blood perfusion in the liver. Limitations of MS method are also discussed. The MS 
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method makes use of key time points, forming the basis of the rationale to explore 
optimization strategies that utilize variable time intervals, rather than the more common 
approach of fixed time intervals. Results show that this leads to significant improvement, 
without compromising diagnostic information.  
In the last section we explore the magnetic shielding efficacy of superconducting 
materials and methods to mitigate the effect of necessary discontinuities in 
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The present work deals with heat and mass transfer and its application to biological 
tissue. We begin by giving basic definitions of temperature, heat transfer and relevant 
laws (thermodynamic) governing energy transfer. 
            Matter consists of atoms and molecules which are in constant motion. This 
motion is in the form of random translational motion, internal vibrations and rotations. 
The energy associated with these motions is referred to as thermal energy or heat. The 
particles possess kinetic energy by virtue of their motion and temperature is a measure of 
average kinetic energy. When molecules with higher kinetic energy collide with 
molecules of lower energy a transfer of energy takes place. This leads to an increase in 
the kinetic energy of the molecules with lower energy. By definition higher kinetic 
energy represents a higher temperature and therefore energy is being transferred from 
higher temperature to lower temperature. This transfer of energy from higher temperature 
to lower temperature is known as heat transfer and is described in detail below. 
1.1. HEAT TRANSFER 
     In this section the basic concepts of heat transfer, relevant to the present work are 
explained. First the different modes of heat transfer are described followed by the 
concepts of thermodynamics (Incropera et.al.). 
2 
 
1.1.1 Modes of heat transfer 
Heat transfer occurs via conduction, convection and radiation. When heat transfer occurs 
within a stationary medium, whether a solid or fluid, it is known as conduction. 
Convection occurs when heat is transferred between a surface and a moving fluid. The 
third form of heat transfer, radiation, occurs when surfaces emit electromagnetic waves as 
thermal radiation.  
Conduction 
In order to explain conduction it is best to start by considering a gas which is 
devoid of any bulk, macroscopic motion and has a temperature gradient. Molecules at 
higher temperature have higher kinetic energy and when they collide with molecules of 
lower energy they transfer energy. In this way there is a net transfer of energy from 
higher temperature to lower temperatures. This is also known as diffusion of energy. The 
case can be easily extended to fluids, the only difference being that the molecules in a 
fluid are closer to each other than in gas and consequently stronger and more frequent 
molecular interactions occur.  
The case of solids is similar to that of gases and liquids but with important 
differences. In a solid, the atoms are arranged in fixed periodic spatial relation known as 
lattice. Here the microscopic motion which is responsible for thermal energy has two 
components. First, due to movements of free electrons and second due to the lattice 
vibrations also referred to as phonons when considering it as a particle like behavior. The 
contribution from electrons is dominant for the case of pure metals, whereas for the case 
of non-conductors and semiconductors it is the heat transfer through phonons which 
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dominates. A special case of conduction occurs in solids with very low electrical 
resistivity and is known as ballistic conduction. It is generally observed when the mean 
free path of electrons is much longer as compared to the dimensions of the material for 
example in metal nano wires.  
      When a metal rod is heated at one end the temperature of the other end also rises 
gradually. The heat transfers from one end to the other by conduction.  
The rate equation used for describing this is known as Fourier’s law and is given in one 
dimension as 
     
      
  
  
                                                                                                                                
where   
  is the heat flux (W/m
2
) or heat transferred per unit area, heat flux, in the x -
direction,   is the thermal conductivity and T is the temperature. 
Convection 
Convective heat transfer takes place when a surface comes into contact with a moving 
fluid and there is a temperature difference between the fluid and surface. Although 
convective heat transfer occurs at the boundary of the two materials, it is also important 
to understand the heat transfer within the fluid, away from the surface for a complete 
understanding of convection. We have seen in the previous section the heat transfer 
through random molecular motion, diffusion. In convection there is an additional 
component to this by the virtue of the motion of the fluid. Due to this bulk motion of the 
fluid, the random molecular motion is also transferred. Heat transfer by this mechanism is 
referred to as advection. Convective heat transfer occurs by both diffusion and advection. 
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So, in addition to the heat diffusing into the fluid at the solid liquid interface, there is also 
heat transfer taking place through advection due to upstream fluid, which has already 
come into contact with the surface and exchanged heat. 
Convection in single-phase fluids can be classified into three forms: 
1. Forced convection: This form of convection is driven by an external stimulus. An 
example of this is cooling of a microprocessor in a computer by a fan. The fan directs 
external air towards the microprocessor. The microprocessor transfers heat to the air 
and cools. The amount of heat transfer achieved can depend on various factors 
including, temperature difference between the incoming air and the microprocessor 
surface, velocity and density of air. 
2. Natural/free convection: Here the fluid flow is driven by buoyancy forces. An 
example of natural convection can be a heated vertical plate. The plate will heat the 
air in its vicinity, the heated air being less dense than the surrounding air will rise. 
The incoming cold air will again get heated up due to the plate and will rise, hence 
continuing the cycle.  
3. Mixed/combined convection: As the name suggests this form of convection is a 
mixture of forced and natural convection. If we have a heated vertical plate, which is 
an example of natural convection and if we add a fan at the bottom, blowing air along 
the walls, this will be the case of mixed convection.  
The rate equation which is used to describe convection is given by Newton’s law of 
cooling. 
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where    (W/m2) is the heat transfer from the ambient air to the surface,   (W/(m2K)) is 
the convective heat transfer coefficient,    (K) is the ambient temperature and    (K) is 
the surface temperature.  
Radiation 
The third form of heat transfer is radiation (thermal radiation). It requires no 
medium and energy is transferred in the form of electromagnetic waves, with 
wavelengths ranging from 0.1 to 100 µm approximately. Any surface which has a 
temperature above 0 K emits thermal radiation. It is the vibrations of the constituent 
molecules or electron transitions, sustained by its internal energy, which are responsible 
for these radiations. As the internal energy is related to temperature this form of radiation 
is associated with thermal energy of the matter. Thermal radiation comprises of infrared 
and visible radiation and a portion of ultraviolet. As high energy electrons transitions to a 
lower state an object emits radiation and a lower energy electron jumps to a higher state 
as it absorbs radiations. Similarly, changes in the vibrational energy of molecules are also 
associated with the absorption and emission of radiations although at much lower 
energies as compared to electron transition. An object emits and absorbs radiations 
continuously, if radiation emission equals absorption the temperature of the object 
remains constant. The temperature of the object increases if absorption dominates and it 
decreases when emission is dominant.  
An example of heat transfer through radiation is the heating of satellites orbiting 
the earth. There is no atmosphere present in space, so there is no possibility of heat 
transfer from conduction and convection. But when the satellite is between the earth and 
the sun, therefore outside the shadow of the sun, it receives radiation from the sun and 
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heats. In fact it is a challenging problem to remove this heat as there is no possibility of 
convection and conduction. Multilayer insulation material is employed for this purpose, it 
reflects most of the radiation.  
The maximum radiation which can be emitted by a surface is given by the Stefan-
Boltzmann law 
      
                                                                                                                                              
where   is the emissive power (W/m2),   (5.67 ×10-8 W/m2. K
4
) is the Stefan-Boltzmann 
constant,    is the surface temperature (K). This is an idealized case, where the surface is 
considered as a blackbody. Real surfaces emit less radiation than a blackbody at same 
temperature, depending on various factors, including material and surface. To incorporate 
this loss in emissive power, emissivity ( ) is defined, which ranges from 0 to 1. After 
including this the emissive power is given by 
      
                                                                                                                                             
where   is the surface emissivity. 
    The radiation incident on a surface is absorbed, and the extent of absorption is 
governed by the absorptivity, α, which ranges from 0 to 1. Surfaces with equal emissivity 
and absorptivity are known as grey surfaces. For grey surfaces the rate equation is given 
as 
    
        
      
                                                                                                                       
where     
  is heat transfer occurring from the surface to the surrounding,      is the 





       In the last section (1.1.1) different modes of heat transfer were discussed. There is a 
need for additional set of laws, known as laws of thermodynamics, to conduct heat 
transfer analysis. 
     The first law of thermodynamics relates to the conservation of energy. It states that the 
change in the total amount of energy stored in a control volume is equal to the net energy 
input into the volume and the energy generated in the volume. This is given by the 
following equation 
                                                                                                                         
where          is the energy stored in the control volume,     is the energy entering the 
volume,      is the energy leaving the body and            is the energy generated in the 
body. 
Using the conduction rate equation (Eq. 1.1) and the first law of thermodynamics (Eq. 
1.6) on a control volume gives us the heat diffusion equation 
   
  
  
                                                                                                                                
 where   is the density (kg/m3),   is the specific heat capacity(J/(kg.K)),   is the thermal 
conductivity (W/(m. K)) and   is the heat generation rate (W/m3). 
       First law of thermodynamics (Eq. 1.6) along with the knowledge of different modes 
of heat transfer is sufficient for conducting heat transfer analysis on wide range of 
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engineering problems. Some of them are designing fan for cooling microprocessor, 
radiators in automobiles, dewar to store cryogenic liquids, HVAC and solar cookers.  
Second law of thermodynamics deals with the direction of heat transfer. It states that 
the entropy of an isolated system cannot decrease over time, where entropy, on a 
microscopic level, is a measure of disorder. Clausius gave mathematical form to change 
in entropy [J/K] 
      ⁄                                                                                                                                  
In a system with objects at two different temperatures, if the heat flows from the hot 
to the cold object the entropy increases, therefore this is the only plausible direction of 
heat flow. Thus the second law of thermodynamics makes it possible to know the 
direction of heat transfer. 
1.1.3 Finite element method 
         The principles discussed in this section can be applied to solve heat transfer related 
problems for simple geometries. However, in the real world, the problem domains are 
complex and have no simple analytical solutions for the underlying partial differential 
equations. Some examples of partial differential equation are heat diffusion equation for 
heat transfer analysis, Navier-Stokes equation for fluid dynamics analysis and bio-heat 
transfer equation for heat transfer analysis in biological tissue. 
To solve this problem finite element method (FEM) is employed, which is one of the 
numerical methods available based on Galerkin method. FEM divides the domain into 
smaller parts, referred as elements, which have common points referred to as nodal 
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points. A polynomial is used to interpolate values within the element. This leads to a set 
of simultaneous equations which can be solved to obtain unknown variables. FEM was 
used by commercial software COMSOL Multyphysics v 4.2 (2011) in the present work to 
solve for the temperature distribution. 
1.2. Bio Heat Transfer 
              Body tissue is a complex system with blood flow and metabolic activity. Apart 
from supplying nutrients the blood flow also affects the temperature of the body tissue. 
The metabolic activity also leads to heat generation, referred as metabolic heat generation 
rate. Understanding the contribution of these two factors in the heat transfer within body 
can be very useful in estimating the temperature distribution within the body. Several 
models have been suggested to describe bio heat transfer (Pennes 1998). Pennes bio heat 
transfer equation has been experimentally validated and used extensively in the literature 
(Pennes 1998). 
      Bio heat transfer as described in Pennes bio-heat equation is very similar to the 
standard heat transfer equation. The heat generation term has two components, metabolic 
heat generation rate and heat transfer through blood perfusion.   
   
  
  
                                                                                                          
where ρb [kg/m
3




] represent density, specific heat of 
blood, arterial temperature and blood perfusion rate respectively.   [W/m3] is the 
metabolic heat generation rate. 
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           To solve the heat diffusion equation, analytically or numerically, domain boundary 
conditions and initial conditions need to be specified. In the present case boundary 
conditions are specified at the inner body and at the outer surface. The outer boundary is 
given a convection boundary condition, which will be explained in detail in the second 
section. The inner body surface is assumed to be at a core body temperature of 37⁰ C, 
which is maintained at this temperature due to thermoregulation.  
 Human body cannot function properly if the core temperature falls below 35⁰ C or 
goes above 42⁰ C. Temperatures beyond this range could lead to brain injury and is fatal. 
The function of thermoregulation in human body is performed by hypothalamus, which 
sends signals to the body to perform the appropriate function. If the body requires cooling 
it undergoes sweating and vasodilation. As the sweat evaporates it cools down the skin in 
the process and as the blood vessels become wider near the skin surface it leads cooling 
of the blood and thereby body. On the other hand if the body requires heating, it leads to 
vasoconstriction (narrowing of blood vessels) and shivering. Vasoconstriction decreases 
the blood flow to extremities and thereby reduces the heat flow from the extremities of 
the body to the surrounding. Shivering, on the other hand generates heat in the body 
because of the rapid movements of the muscles. All these process allows hypothalamus to 
control internal body temperature at 37⁰ C. 
  There are certain conditions which dysregulate temperature control, some of them 
are staying in cold or hot conditions, exercise and digestion. It can also be an indication 
of some abnormal functioning of the body, as fever, under functioning thyroid gland, 
inflammation and tumor can also lead to an increase or decrease of temperature. Tumor is 
dealt in more detail later. 
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         There are certain parameters which are more influential in the temperature 
distribution within the body, as compared to other parameters. Based on analysis 
conducted by Çetingül and Herman (Çetingül and Herman, (2010)) blood perfusion rate 
and metabolic heat generation rate were found to be the most dominant parameters 
affecting the heat transfer distribution within the tissue.  
1.3. Thermography 
       There are various instruments available to measure temperature, including 
thermocouples, thermistors, resistance thermal detectors and infrared cameras. Of these 
only infrared cameras (thermography) can provide a spatial temperature distribution and 
the rest can give temperatures only of a single point at a time. The knowledge of spatial 
variation is critical in a clinical setting while diagnosing a disease, based on surface 
temperature distribution. The basic concepts involved in thermography are described 
below.  
       A blackbody at any given temperature emits radiation across a wide range of 
wavelengths. The intensity of radiation at each wavelength is dependent on the 
temperature of the blackbody and can be obtained by the Stefan-Boltzman law. It is 
interesting to note that sun (5800 K) emits radiations of maximum intensity within the 
visible spectral region. Eyes of human beings have evolved to maximize the utilization of 
that part of the solar radiations which has maximum intensity. Similarly infrared cameras 
also utilize that part of the radiation which has maximum intensity. For human 
applications the working temperature range is around room temperature. At room 
temperature the intensity peaks around 10 μm, therefore the sensors in infrared camera 
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are designed to measure radiation around this wavelength. The images obtained from 
infrared cameras, showing the temperature distribution, are referred as thermograms.  
         Infrared cameras were first used around 1950s and have undergone tremendous 
improvements, from bulky units to hand held cameras. They have various applications 
including night vision cameras, which detects the heat signature left by humans and other 
animals to detect their activity during night, when visibility is low or absent. The earliest 
infrared cameras had spatial and temporal resolution of 5 mm and 0.3 - 1 K respectively. 
Over the years, with technological advancement, spatial and temporal resolution has 
improved to 0.003 mm and 5 mK, respectively. ( Cetingul M. P. 2010 )  
          Among other uses it can also be used on humans and other animals for diagnosing 
purposes. Abnormalities in the human tissue, caused by diseases, lead to local 
temperature variations (Barnes 1963). This is a common observation in the case of skin 
cancer (Herman 2012), breast cancer (Ng 2009), hemangioma (Saxena and Willital 2008)  
and deep tissue injury (Bhargava et al. 2014). Infrared cameras can be used to detect 
these temperature variations and therefore can aid in diagnosing diseases (Ng 2009).  
           A significant amount of work has been done in qualitative analysis of breast 
cancer infrared images (Ng, E. Y. -K., 2009). The asymmetry in temperature distribution 
is used as an indicator of abnormalities. Researchers have also shown interest in 
extracting quantitative thermograms. The heat transfer within the human tissue is 
modeled and then the surface temperature data are used to determine internal features. 
This aspect is dealt with in great detail in chapters 2, 3 and 4 of the present work. 
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           Other applications of thermography are in skin hemodynamics (Anbar et al. 1997), 
plaque (Bahtia et al. 2003), food allergies (Clark et al. 2007), Cataract (Corvi  et al. 
2006) and extracranial-intracranial bypass surgery (Okada Y. 2007). 
1.4. Tumors 
          Tumors can be categorized into cancerous, or ‘malignant’, and non-cancerous, or 
‘benign’. Malignant tumors are highly heterogeneous in nature and variations are found 
even within the same cancer types. Not all tumors are solid, sometimes they have cysts or 
liquid areas. Some regions of tumors are characterized by necrotic regions, which are 
deprived from blood supply. The periphery of the tumor is where all the activity is 
concentrated and is highly perfused.  
    Malignant tumors have a high growth rate and therefore a high metabolic rate due to 
which it generates more heat as compared to the normal tissue. Due to fast growth rate it 
also needs higher supply of nutrients, which leads to angiogenesis, and therefore these 
regions are highly perfused. Both these factor leads to elevated temperature in its vicinity 
( Lawson 1956, Kennedy et al. 2009 ) This elevated temperature can also be observed on 
the surface and can be recorded using infrared camera.  
         The severity of cancer can be seen from the fact that in 2012, the total number of 
new cancer cases, all over the world, was 14 million, and around 8 million deaths were 
reported (NIH-NCI). Within the US it is estimated that 1.7 million new cases and 0.8 
million deaths will be observed in 2016. According to an estimate, based on 2010-12 
data, around 40 % of men and women in US will develop some form of cancer in their 
lifetime. Breast cancer, lung and bronchus cancer and prostate cancer are the most 
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prevalent forms of cancer. Large amounts of money have been spent in US to fight 
cancer. $125 billion was spent in 2010 and an estimated $156 billion will be spent in 
2020. Still, there were 14.5 million people in 2014 that were not able to get cancer 
diagnosis.  
            In the present work the focus has been on the second most common forms of 
cancer in women, breast cancer and the cancer with one of the highest 5 year mortality 
rate, liver cancer. Based on breast cancer statistics, the lifetime probability of developing 
breast cancer is 12.3 % (1 in 8) for women in the U.S. (Siegel et al. 2016). In 2016, 
around 246,660 new cases and around 40,450 deaths are expected to be reported in the 
U.S. alone (National Cancer Institute, 2016).  Early detection of breast cancer is currently 
the most effective way to fight the disease.    
         The spread of tumor cells from the place of formation to another part of the body is 
known as metastasis. In this process tumor cells break away from primary tumor, travel 
through the blood and lymph system and form a new tumor in other organs or tissue of 
the body. Cancer diagnosis at an early stage can prevent metastatic growth of the tumor. 
It becomes extremely difficult to treat someone with tumor metastasis, therefore the role 
of early diagnosis becomes extremely important. Any progress in this direction can prove 
very fruitful in terms of saving lives. Therefore in the present we have focused on cancer 
diagnosis and tumor characterization.  
1.5. Inverse Heat Transfer   
          The problem of estimating the underlying parameters from the observable data is 
called “inverse problem”. It can be as simple as calculating gravity by measuring the rate 
of descent of a falling body and as complex as estimating tumor characteristics using 
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surface temperature distribution. Inverse problems are encountered in various fields of 
science and engineering, such as non-destructive testing, medicine, geology, archaeology, 
oceanography, material science and astrophysics. Inverse problems in heat transfer are 
referred to as inverse heat transfer (Ozisik M N and Orlande H 2000). An example of 
inverse heat transfer is to estimate the intensity of an internal heat source from the surface 
temperature distribution. 
           Inverse heat transfer has application in aerospace, mechanical, chemical and 
nuclear engineering. An example of its application in aerospace engineering is in 
designing the insulation tiles of the space shuttle. Due to extreme conditions it is 
impossible to measure the heat flux of the tiles directly. So the temperature within the tile 
is measured and from this the heat flux at the outer surface is estimated. It has also been 
applied in cancer diagnostics and characterization. 
              Different methods are used to solve the inverse problems, including genetic 
algorithm, neural networks, Levenberg-Marquardt method and various gradient descent 
algorithms. Inverse heat transfer problems are inherently ill-posed (Ozisik M N and 
Orlande H 2000), as a small change in the observed data can have significant effect on 
the estimation of underlying parameters. In order to tackle this problem regularization 
methods are used. One such widely used method is the Levenberg-Marquardt method. 
The Levenberg-Marquardt method is a common method for solving non-linear 
optimization problems. It is a combination of gradient descent method and Gauss Newton 
algorithm. The gradient descent part dominates when the solution is far and Gauss 
Newton approach dominates when the solution is close. An advantage of this method 
over other methods such as genetic algorithm and neural network, is that it does not 
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require test cases to run. This can prove helpful in clinical settings where test cases will 
be required for each and every case, while for LM method there will not be such 
requirement. 
1.6. Superconductivity 
Superconductivity is a phenomenon where the electrical conductivity of a material 
becomes zero below certain characteristic temperature known as critical temperature. 
Critical temperatures are generally below 100 K and therefore it is important to ensure 
proper insulation for the superconducting material (cables, wires). Without proper 
insulation, large temperature gradients develop which can lead to the heating of the 
system, which in turn can lead to temperature rise of superconducting material above its 
critical temperature and destroy it. Therefore heat transfer analysis is an important aspect 
for superconductivity applications. 
1.7. Overview 
        In the first part of this thesis (Chapter 2-4) heat transfer is modeled within the 
body to relate the tumor parameters, such as tumor size, depth and blood perfusion, with 
the surface temperature distribution. Chapter 2 starts with a description of diagnostic 
modalities for breast cancer, mammography and infrared thermography. It is followed by 
the computational model for breast cancer. This model is used in chapter 3 to analyze the 
effect of various geometrical and thermophysical properties on steady state temperature 
profile. This is followed by the analysis of the effect of application of cooling load on 
temperature distribution. With this background, Chapter 4 estimate tumor parameters, 
size, location and blood perfusion rate, based on the surface temperature distribution in 
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steady and transient state, which is easily available, thus providing a non-invasive method 
of tumor diagnosis and characterization.  
        Heat transfer within the body is very sensitive to blood flow (perfusion). Therefore it 
becomes important to study it in detail. The next part of this thesis deals with 
measurement of blood perfusion within the body tissue using computer tomography (CT) 
perfusion (Chapter 5-6). Different methods used in literature for CT perfusion are 
discussed here. CT perfusion in itself is a diagnostic tool for liver cancer. In liver the ratio 
of the portal vein and hepatic artery, two blood vessels supplying blood to the liver, is 
used to ascertain the possibility of a tumorous region. As an extension to the analysis of 
CT perfusion, an optimized protocol of CT perfusion is developed to reduce the radiation 
dose. A critique of a widely used method for CT perfusion is also included in that section.  
       Towards the end of this work, an application of heat transfer in the extreme 
environment of cryogenic temperatures, superconducting materials, is examined (Chapter 
7). Superconducting materials are capable of shielding magnetic fields. In this section the 
shielding efficacy of superconducting materials, under different circumstances, is tested.   
The use of superconducting materials is only possible when very low temperatures 
(below 100 K) can be obtained and maintained. There are commercially available 
cryogenic vessels, dewars, which are vacuum insulated and used for storing cryogenic 





Breast Cancer: Diagnosis and Characterization 
 
2.1 INTRODUCTION 
Human breast comprises multiple tissue layers but the most common regions for 
the breast cancer are the mammary glands (ductal tissue), although it also sometimes 
occur in the stromal tissue. Ductal carcinoma, invasive and in situ, is the most common 
form of breast cancer. Tumors have abberant growth with higher metabolic activity and 
angiogenesis/neovascularization. Depending on biology, stage and growth it can be 
present with unusual and extensive necrotic regions. 
         Staging of the breast cancer is based on the size of the tumor, its presence in the 
lymph nodes, the extent of its spread in the breast and the rest of the body. Based on the 
stage and type of breast cancer the treatment path can be decided. Some of the treatments 
are lumpectomy, mastectomy, lymph node dissection, chemotherapy, radiation therapy, 
hormonal therapy, targeted therapies and complimentary medicine. With extensive 
treatment plans available it becomes important to detect and characterize tumors to give 
the best possible treatment at the right time. Further, tumors are geographicaly, 
etiologically and pathologically hetrogenous and therefore it becomes much more 
important to study it on a case by case basis before deciding on a treatment.  
                         Various test methods, such as X-ray mammography, biopsy, ultrasound, 
magnetic resonance imaging (MRI) and infrared (IR) thermography have been used in the 
past to detect breast cancer. Although X-ray mammography, ultrasound and MRI are 
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non-invasive and can accurately measure the location and size of the tumor, they provide 
insufficient information to determine whether a tumor is benign or malignant. In order to 
ascertain the diagnosis, a patient has to endure multiple screenings, which can take 
precious time and lead to further progression of the disease.  
Mammography 
                Among all modalities, X-ray mammography is considered to be the gold 
standard for breast cancer detection. Since the early 1960s, it has been the most widely 
used tool for breast cancer detection, but it has some significant limitations including 
radiation exposure, cost, patient discomfort, and more important, a high false positive rate 
( Sobti et al. 2005 ). Table 2.1 shows that the sensitivity (true positive rate) for this 
modality reduces with decreasing age, it is as high as 81 % for women older than 64 
years and it drops to 54 % for women younger than 40 years. Further the results are 
inaccurate for “dense glandular tissue (Osako et al. 2007, Jackson et al. 1993, Kennedy et 
al. 2009), implants, fibrocystic breasts or for those on hormone replacement therapy”  ( 
Harvey et al. 1997, Fletcher et al. 2003, Hoekstra 2001, Kennedy et al. 2009 ).  
It has also been reported that harmful effects of radiation exposure associated with 
mammography outweighs the benefits for women below a certain age (Berrington de 
Gonzalez 2005, Law 2007). Finally, due to pressure applied during mammography there 
are high chances of tumor rupture which may lead to the mixing of the malignant cells 





Table 2.1:  Sensitivity (true positive rate) of mammography (Rosenberg 1998, Bronzino 
2006) 
 Sensitivity 
Less than 40 years 54 % 
40-49 years 77 % 
50-64 years 78 % 
More than 64 years 81 % 
  
Women with dense breast 68 % 
Women on estrogen replacement therapy 74 % 
   
 As an alternative, it is also possible to detect cancerous lesions using 
thermal imaging (IR thermography), a technique which is non-invasive and more 
comfortable for patient. Thermography is based on the fact that malignant tumors 
generate excess heat because of increased metabolic heat generation and they also require 
an increased supply of blood to support growth of cancerous cells. The increased heat 
generation underneath the skin surface causes increased surface temperatures and 
characteristic thermal signatures, which can be visualized by IR thermography (Kennedy 
et al 2009, Lawson 1956). The technical details on IR thermography are covered in 
chapter 1 (Introduction). In 1957 Lawson was the first to use thermography for diagnosis 
of breast cancer (Lawson 1957, 1958, Lawson and Chughtai 1963, Cross ref. E. Y. -K. 
Ng 2009). During the past few decades, IR thermography has been increasingly used for 
breast cancer detection and has been proven to be a promising adjunct diagnostic tool (Ng 
2009, Kennedy et al 2009). It is non-invasive in nature and equipments are relatively less 
21 
 
expensive than some other diagnostic modalities, such as MRI. A comparative study of 
mammography and infrared imaging was done by Head et al. 1999 and is shown in Table 
2.2. 
   Table 2.2:  Comparison between mammography and infrared imaging (Head et al. 
1999) 
 Mammography Infrared imaging 
Sensitivity 86 % 86 % 
Specificity 79 % 89 % 
Positive predictive value 28 % 23 % 
Negative predictive value 92 % 99.4 % 
 
Thermography as an adjunct technique 
 Infrared thermography has been approved by FDA in 1982 as an adjunctive 
technique (Arora et al. 2008). In 1998 Keyserlingk et al. conducted a study to analyze the 
effectiveness of thermography as an adjunct technique. For ductal carcinoma detection, 
the sensitivity for clinical examination, mammography and infrared imaging was 61 %, 
66 % and 83 % respectively. When infrared imaging was added with suspicious and 
equivocal mammograms the sensitivity increased from 85 % to 95 %. This further 
increased to 98 % with an addition of clinical examination. They observed that 
thermography and mammography were unable to detect tumors of less than 12.8 mm and 
16.6 mm diameter respectively. When infrared imaging (thermography) was used with 
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clinical examination and mammography they together were able to identify 95 % of the 
cases (Jiang et al. 2005). Ng 2009 in his review of thermography for detection of breast 
cancer concluded that in last 15 years the thermographic tests on breast cancer have 
achieved specificity and sensitivity of 90 % on an average provided the tests are done by 
trained people and the tests are conducted according to the “strict standardized 
thermogram interpretation protocols”.  
Thermography: prognostic significance 
                    Thermography also has prognostic significance. “Thermography has the 
ability to detect breast cancer 10 years prior to mammography” (Dixon 1999). The 
prognostic significance is highlighted by a study performed by Handley in 1962 in which 
they discovered that patients with a 1-2ᵒ C rise had reduced chances of recurrent cancer 
than the patients with 3ᵒ C rise. (Keyserlingk et al. 2000). A longitudinal study conducted 
by Gautherie and Gros (1980) reported that thermography was able to detect cancer at an 
earlier stage, compared to other modalities, such as mammography (the gold standard), 
ultrasonography and biopsy. This study was conducted over 12 years on a group of 1245 
women with an abnormal thermogram. Their condition was initially diagnosed as normal 
or benign, based on conventional diagnostic modalities, including mammography, 
ultrasonography and biopsy. One-third of the women in this study developed breast 
cancer within next five years. These results suggest that thermography was better able to 
detect breast cancer at a very early stage of the disease, when conventional methods 
failed. Therefore, these researchers concluded that thermography, used in conjunction 
with other diagnostic modalities, can improve the early detection of breast cancer. (Isard 
1984, Bronzino 2006). Combined with other imaging modalities, details about size and 
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location of the tumor can be obtained in addition to the heat generation rates that IR 
thermography can address.  
                    “Recent advances in cancer research have determined that the biological 
activity of a neoplasm is far more significant an indicator of aggressiveness than the size 
of the tumor” (Bronzino 2006). The amount of heat generated is directly related to the 
degree of metabolic activity which is measurable in the form of surface temperature 
distribution. 
Dynamic thermography 
            “Nagasawa and Okada (1973) reported that in order to better differentiate breast 
cancer from benign breast disease, thermography should be done during thermal 
recovery,” Ohashi and Uchida 2000 used dynamic thermography to diagnose breast 
cancer. They reported considerable improvement in diagnostic accuracy (82% as 
compared to 54% in steady state thermography) but there was no improvement in the 
false positive rate they attributed this to the image processing system. 
 Quantitative Thermography 
                  As of now thermography practice is subjective and the diagnosis is based on 
asymmetry, hyperthermic patterns and “complex vascular features” (Kennedy et al. 
2009).  There is a need to quantify the whole process. Theoretically it is possible to 
determine the size and location of the tumor based on the surface temperature distribution 
and the current work examines these aspects of thermography. Further the impact of the 
thermophysical properties on the surface temperature distribution has been analyzed and 
it is possible to get a fair estimate of the thermophysical properties based on the surface 
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temperature distribution. It is important to note that all this information can be retrieved 
based on non-invasive technique thermography.  
In the past (Jiang et al. 2005, Ng and Fok 2003, Ng et al. 2001, Ng and Kee 2008) 
many computer aided tools have been used to assist doctors to make diagnostic decisions. 
These include artificial neural network (ANN), bayesian belief networks, linear 
discriminate analysis, fuzzy logic and fusion of fuzzy logic and ANN. Bayers rule 
analysis was used by (Ng et al. 2001). It had a low total accuracy of 59 % but as high as 
74% of the patients had a true positive test (positive predictive value of 74 %). In 2008 
Ng and Kee analyzed thermograms using ANN and bio-statistical methods. The method 
developed by them was able to achieve 80.95 % accuracy rate, 100% sensitivity and 70.6 
% specificity. 
            Gautherie (1980) also observed that the metabolic heat generation rate is higher 
for tumors with a faster growth rate, and established a relationship between metabolic 
heat generation and cancer growth rate. Further, he observed that tumors with a higher 
growth rate had a high probability of dissemination. Thus, estimation of the metabolic 
activity of the tumor from surface temperature measurements can provide a measure of 
the malignancy of the tumor. This can prove to be an added advantage of IR 
thermography over other diagnostic modalities. It should be noted that high 
vascularization necessary to support accelerated malignant cell growth can be quantified 
in terms of the local blood perfusion rate. Therefore both increased metabolic activity 
(heat generation) and increased blood perfusion can serve as markers of malignancy. 
Prior studies on melanoma (clinical and computational modeling: Pirtini Çetingül and 
Herman, 2010) and breast cancer (computational modeling: Chanmugam et al, 2012) 
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suggest that the influence of blood perfusion on the thermal signature of the cancerous 
lesion is more pronounced than metabolic heat generation rate.  
Therefore, it can be said that till date, thermography has been a largely qualitative 
technique, and diagnosis was based on qualitative criteria such as asymmetry, 
hyperthermic patterns and abnormal vascular patterns (Kennedy et al 2009). Usually, the 
quantitative information extracted was the temperature increase at a location selected by 
the person interpreting the image, compared to the temperature of a nearby region 
unaffected by the lesion or the corresponding contralateral location. A need exists to add 
additional quantitative components to the interpretation of thermal images, so that vital 
information about the tumor, such as size, location, metabolic activity and, most 
importantly, stage can be extracted from the thermograms. The problem of extracting the 
model parameters (location, size, perfusion) from the observable surface temperature data 
is known as the ‘inverse problem’ and will be dealt with in chapter 3. In the next section 
The mathematical model used to model heat transfer within the breast tissue is described 
in the next section. 
2.2 MATHEMATICAL MODEL 
        The schematic of the investigated geometry is displayed in Figure 2.1. The breast 
shape can vary, and in this study it is modeled as a hemisphere. In clinical applications 
the actual shape can be measured by a 3D imager, such as the Kinect, motion sensing 
input devices. We consider a single tumor, which is spherical in shape and is located at 
the axis of the hemisphere. Other shapes, such as elliptical, can also be used, which 
would introduce additional unknowns to be determined in the inverse reconstruction. By 
selecting the axially symmetrical two-dimensional (2D) problem in this analysis, the 
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computational effort is kept reasonable in the initial testing stage of the reconstruction 
algorithm. Also, the interpretation of the results is more intuitive and algorithm progress 
is easier to track for the two dimensional case. Our previous study shows that the thermal 
signature of the tumor on the skin surface will be very similar for off axis locations 
(Chanmugam et al, 2012). The approach can easily be generalized to a three-dimensional 
(3D) problem, such as those discussed by Chanmugam et al. (2012), at a later stage and 
this would require improvements in the meshing of the direct problem. Further, it is 
assumed in the model that the thermophysical properties of the tissue and tumor are 
known.  
The overall goal of the inverse reconstruction is to non-invasively measure key 
tumor parameters, the depth and size of the tumor. Since the blood perfusion rate can be 
related to malignancy, we add blood perfusion as the third parameter in our analysis. The 
inverse problem is solved for two cases, the first deals with steady state analysis, while 
the second case deals with a transient situation. For steady state, we reconstruct two 
unknown tumor parameters, the depth of the tumor measured from the skin surface ( ) 
and the radius of the tumor ( ) (Figure 2.1). In transient analysis we reconstruct a third 
unknown, the blood perfusion rate     .  
Human breast tissue in this analysis comprised six layers: epidermis, papillary 
dermis, reticular dermis, fat, gland and muscle as well as the tumor, the seventh region, as 
indicated in Figure 2.1. The Pennes bioheat equation (Pennes (1948)) was used to model 
heat transfer in the layers of the breast and in the tumor as 
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In Equation (2.1)    [kg/m
3




] represent the density 
and specific heat of blood, the arterial blood temperature and the blood perfusion rate of 
the tissue layer  ,  respectively.     [kg/m
3
],    [J/kg.K],   [K],   [W/m.K] and 
  [W/m
3
], are the corresponding tissue properties: density, specific heat, temperature, 
thermal conductivity and metabolic heat generation. The thermophysical properties for 
the seven tissue types are summarized in Table 2.3 along with their thicknesses (thn), 
based on data reported by Pirtini Çetingül and Herman (2010), Ng and Sudharsan (2001), 
Amri et al. (2011) and Jiang et al. (2011).  Density (  ) and specific heat (  ) for blood 
were 1060 kg/m
3
 and 3770 J/(kg.K), respectively (Pirtini Çetingül and Herman (2010)). 
The radius of the hemi-spherical breast V was taken to be 72 mm (Ng and Sudharsan 
(2001)) (figure 2.1). Blood perfusion rate and metabolic heat generation rate were tumor 
specific and also depend on the stage of the tumor. One of the plausible set of values is 
given in Table 2.3.  
 
Figure 2.1: Schematic of the biophysical situation: breast cross section, tumor, tissue 



























































Table 2.3: Thermophysical properties of the tissue layers in Equation (2.1) 
 
a
 Pirtini Çetingül and Her man (2011) 
b
 Ng and Sudharsan (2001) 
c
 Amri et al (2011) 
d
 Jiang et al (2011)  
The system of seven coupled partial differential equations described by Equation 
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Heat flux continuity and the temperature continuity at the interfaces of two tissue 
layers:  
  
   
  
     
      
  
                                                                                                    
                                                                                                                                     
  
   
  
     
      
  
                                                                                                                    
                                                                                                                                                 
where   is the direction perpendicular to the interface between the layers,     and      is 
the thermal conductivity and temperature of the tissue layer adjacent to the tumor. The 
inner portion of the muscle layer, the region of the breast which touches the chest wall, is 
assumed to be at the core body temperature  
                                                                                                                        
The skin surface is exposed to ambient air during the exam, which leads to loss of 
heat to the atmosphere, described by the convective boundary condition as  
   
   
  
  (       )                                                                                                               
where   = 10 Wm-2K-1,    = 0.235 Wm-1K-1,    = 21   
where   is the convective heat transfer coefficient    is the thermal conductivity of the 
epidermis, the outermost tissue layer, T1,s is the temperature of the epidermis at the skin 
surface in contact with air and   is the direction perpendicular to the skin surface. 
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         Dynamic IR imaging involves cooling of the skin surface and analysis of the 
transient thermal response to the excitation. Initially the skin surface is at steady state 
under ambient conditions. It is cooled by maintaining the surface at 14   for time   . 
This is modeled by using constant temperature boundary condition.  
                                                                                                                                
         The cooling in our analysis is applied for the duration of     60 s (Cheng and 
Herman (2014)). It should be noted that here computational phantom is being used. 
Subsequently the surface is again exposed to the ambient conditions in the exam room 
and hence the convective boundary condition (equation (2.7)) is applied on the surface. 
This reheating process following the exposure to cooling is called the thermal recovery.  
Surface temperature data in this study are computed or recorded for 1000 s during the 
thermal recovery process.  
The system of seven partial differential equations (2.1) is solved, subject to 
boundary conditions (2 - 8) using the commercial software COMSOL Multiphysics v 4.3 
(2013). A MATLAB code was developed for solving the inverse problem. While solving 
the inverse problem in MATLAB, COMSOL was accessed to compute temperature 
distributions for a given set of input parameters updated by the inverse reconstruction 
algorithm. For the purpose of communication and control of COMSOL by means of 
MATLAB, the LiveLink for MATLAB was used. The PC computer system used to run 
the present model was equipped with an Intel core i-7 processor, with 3.4 GHz frequency 
and 32 GB RAM. A typical mesh generated for the computational domain contains 8,000 
elements (figure 2.2(a)). It takes about 6 seconds to solve the set of equations for steady 
state analysis and about 16 seconds for the transient analysis. Mesh sensitivity analysis 
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was carried out to ensure that the change in temperature, due to further refinement of the 
mesh, was less than 0.1 %. The choice of the time step was governed by two factors, 
computational speed and accuracy. A smaller time step increases the accuracy but it also 
leads to increase in computational time. For the present case a time step of 2 seconds was 
taken as the temperature change was less than 0.1% after decreasing the time step. The 
steady state temperature distribution in the cancerous breast for the conditions described 
by equations (2.1-2.8), obtained using COMSOL, is shown in figure 2.2 (b). 
This section is divided into two parts. In the first part (Chapter 3) cancerous breast 
model is analyzed, the effect of various parameters on the surface temperature is studied. 
Second part (Chapter 4) focuses on solving the inverse problem of detecting tumor 








Figure 2.2: (a) Computational mesh, (b) computed temperature distribution in the cancerous 
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Thermal Analysis of Cancerous Breast Model 
The complete authorship of this work should be read as Dr. Arjun Chanmugam, Rajeev 
Hatwar and Prof. Cila Herman. The development of computational model and the 
analysis was performed by Rajeev Hatwar under the guidance of Prof. Cila Herman and 
Dr. Arjun Chanmugam. This work was published in International Mechanical 
Engineering Congress Exposition 2012 (Chanmugam, Hatwar and Herman 2012). 
3.1 INTRODUCTION 
               Thermography (Infrared imaging) has been around since the late 1950s, but the 
mechanisms of heat transfer between diseased and native tissue and the differences 
between the two have yet to be well described. Previous studies indicate that tumors 
generate more heat than healthy tissue and this temperature difference can be identified 
by using steady state thermal imaging (Lawson 1956, Kennedy et al. 2009 ). Despite the 
technological advances made with infrared imaging, thermographic imaging largely 
remains qualitative in nature (Kennedy et al. 2009) which limits its utility. 
              Researchers have used computational modeling to relate the skin surface 
temperature distribution to tumor size and location for breast cancer (Osman and Afify 
1984, 1988 , Sudharsan et.al.1999, Sudharsan and Ng 2000, Ng and Sudharsan 2001, 
Jiang et al. 2011). Osman and Afify (1984, 1988) were one of the first using a 
hemispherical model with different tissue layers of uniform thickeness. Later Sudharsan 
and Ng (2000, 2001) used models which adequately depicted the breast anatomy. Jiang et 
al (2011) have incorporated elastic deformation in their modeling. 
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               Mital and Pidaparti 2008 and Mitra and Balaji 2010 used evolutionary 
alogrithms and neural networks respectively to predict tumor size and location using 
breast thermograms. In their analysis the metabolic heat generation rate was varied with 
tumor diameter, whereas the blood perfurion rate of the tumor was kept constant. 
               In this study, we present a quantitative analysis to provide a more accurate 
description of the thermal characteristics of breast cancer lesions including the 
dependance of the temperature distribution on size, shape, and depth of the lesion. 
Specifically we used a parametric analysis of the breast to obtain a set of features that can 
be used to predict the location and size of the breast cancer lesion from surface 
temperature measurements, which is essential in diagnostic applications. In order to 
improve thermal image acquistion procedure and ensure reproducibility and accuracy of 
the imaging procedure, a cooling load was applied in the analysis to enhance the thermal 
visibility and allow meaningful measurements of the physical and thermophysical 
characterisitics of the lesion. This work should allow clinicians a more accurate, 
noninvasive and cost effective tool in the early diagnosis of one of the most common and 
dangerous cancers.      
3.2 NUMERICAL MODELING 
         The dimensions of these layers are given in Table 3.1. In order to investigate early 
stage cancer, the tumor diameter has been kept under 20 mm (Hammer et al. 2008). The 
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 respectively. These values are close to the values used by Ng and 





  The commercial software COMSOL Multiphysics v 4.2 (2011) was used to solve these 
equations, which uses FEM to solve the underlying equations. The mesh generated in 
COMSOL is displayed in figure 3.1 (b). The mesh is finer for thin layers (epidermis, 
papillary dermis and reticular dermis) compared to other layers. In order to ensure the 
mesh independence we tracked the temperature of a point on the axis located on the 
surface and the average surface temperature. The grid points were varied from 5000 to 
29000 and the temperature difference was less than 0.1 %. To ensure that the transient 
analysis is independent of the time step, the surface temperature at the axis was tracked. 
The variation in temperature was less than 0.1% when the time step was varied from 0.1 
seconds to 2 seconds. Hence a mesh with 7800 grid points and a time step of 1 s (the time 
step was 0.1 s for the initial 10 s) were used.  
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Figure 3.1: (a) Schematic of the breast used in the computational model. The various tissue 
layers are epidermis, papillary dermis, reticular dermis, fat, gland and muscle layers. It is 2D 
axisymmetric model and has a spherical tumor centered at the axis. (b) The domain is divided 
into numerous smaller regions comprising of elements. The computational mesh hence 







 Cetingul and Herman 2010 
b
 Sudharsan and Ng 2000 
c
 Ng and Sudharsan 2001 
d
 Amri et al. 2011 
e
 Jiang et al. 2011 
3.3 Results and discussion 
        In this section computational simulation results are presented and discussed. The 
analysis is divided into two parts, steady state and transient. In steady state analysis the 
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effect of tumor size and location on the surface temperature is studied. Based on this 
analysis two key features were identified, which can be used to predict the tumor 
characteristics. In addition, a parametric study is carried out to investigate the effect of 
blood perfusion rate and metabolic heat generation rate of the tumor on the surface 
temperature. The second part of this section focuses on the transient analysis and the 
propagation of the cooling effect into the tissue. The effect of cooling time and cooling 
temperature on the thermal contrast on the skin surface, obtained during recovery phase, 
is analyzed. 
 
3.3.1 Steady State Analysis 
      Figure 3.2 (a) shows the isotherms for the half cross section in a model of a normal 
breast during steady state. The temperature decreases through the tissue towards the skin 
surface. The isotherms for cancerous breast are shown in figure 3.2 (b). Near the tumor 
the isotherms become distorted and indicate that the tumor has higher temperature when 
(a) (b) 
Figure 3.2: (a) Isotherms for normal breast (b) isotherms for cancerous breast 
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compared to the normal tissue.  This increase in temperature is also visible on the skin 
surface.  
Effect of tumor size and depth  
 The surface temperature, T, along the circumference of the breast is displayed 
in figure 3.3(a). The surface temperature profiles for different sizes (r, tumor radius) and 
locations of the tumor (d, depth beneath the skin surface) are plotted along with the 
temperature profile for a normal case. The results suggest there is temperature increase in 
the range from 0.1°C to 0.8°C, and these increases can be accurately measured by 
modern infrared cameras, which have temperature and spatial resolution of 10 mK and 
0.05 mm respectively. The difference in temperature, ΔT, between the cancerous and 
normal (without lesion) case (bottom blue line in figure 3.3(a)) is plotted in figure 3.3 (b) 
to analyze the effect of tumor. As expected, for an axisymmetric tumor, the maximum 
temperature rise, ΔTmax, is detected at the axis. For a fixed tumor radius of 5 mm, the 
maximum temperature difference increased from 0.08 °C to 0.58 °C as the depth of 
tumor is decreased from 20 mm to 10 mm. Similarly, for a fixed depth of 15 mm, the 
maximum temperature difference increased from 0.03 °C to 0.50 °C as the radius of the 
tumor is increased from 2.5 mm to 7.5 mm. All other properties remained the same.  
           The dependence of the maximum temperature difference on tumor size and depth 
is shown in figure 3.4 (a). The result agrees with the observation made by Amri et al. 
2011 that the presence of tumor is always accompanied with an increase in surface 
temperature. The temperature rise might be very small but it is always present even for 
very a small tumor. It is clear from the figure 3.4 (a) that as the tumor size increases for 
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fixed depth and as the depth of the tumor decreases for fixed diameter, the maximum 
temperature difference increases.  
         According to a similar analysis done by Amri et al. 2011 and Jiang et al. 2011, they 
obtained negligible variation in maximum temperature difference with varying tumor 
size. In their analysis they used equation 
Q = C/(468.6 ln 200 r + 50)                                                                                         (3.1) 
to calculate metabolic heat generation from the diameter of the tumor. According to this 
expression, the metabolic heat generation rate decreases with increasing size. Due to this 
decrease, the effect of increasing size of tumor is countered by the decreasing metabolic 
heat generation rate, and therefore there is no significant change in maximum surface 
temperature as the size of the tumor varies. Therefore, the mismatch between the results 
obtained here and that given in literature is due to the variation in metabolic heat 
generation rate. In order to do a comprehensive analysis we assume that the metabolic 
heat generation rate is independent of the tumor diameter. We treat it as an independent 
parameter, which is more consistent with clinical observations both large and small 
tumors can be aggressive and have large metabolic heat generation rates, and vice versa.   
            While figure 3.4 (a) is helpful to understand the behavior of maximum 
temperature rise as the depth and size of the tumor are varied, this result alone cannot be 
used to estimate the location and size of the tumor. The analysis suggests that the same 





        
             The results in figure 3.3 (b) indicate that the slope of the temperature difference 
curve increases (it becomes steeper) with decreasing tumor depth. Here ‘half temperature 
difference length’ (LT), is used as a measure of this slope. It is defined as the distance 
from the axis along the circumference at which the temperature difference drops to half 
its maximum value. As the slope of the temperature profile increases, the corresponding 
LT decreases. Figure 3.4 (b) shows the variation of the half temperature difference with 
size and depth of the tumor, and the results indicate that LT decreases with decreasing 
depth and radius. When LT is used along with maximum temperature difference, the 
location and size of the tumor can be estimated. Even though there are different 
combinations of radius and depth which gives same ΔTmax (figure 3.4 (a)), those 
particular set of combinations will not give the same LT (figure 3.4 (b)) as can be clearly 

























d = 10 mm, r = 5  mm 
d = 15 mm, r = 2.5  mm
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d = 10 mm, r = 5 mm
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d = 15 mm, r = 5 mm
d = 20 mm, r = 5 mm
d = 15 mm, r = 2.5 mm
T = T - T
n
(a) (b) 
Figure 3.3: (a) Surface temperature along the circumference of the breast, starting from 
the axis, for tumors radius r and tumor depth d as parameters.(b) The rise in surface 
temperature due to the presence of tumor, ΔT, has been plotted here. It increases with 
increasing tumor radius for a fixed tumor depth of 15 mm and with decreasing tumor 







seen from figure 3.4. The size and depth of the tumor are the only variables in this 
analysis, and metabolic heat generation and blood perfusion rate were kept constant.       
 
Off-axis tumors 
In the foregoing analyses, we largely considered tumors that were symmetrical around 
the axis. In this section off-axis tumors are analyzed by varying the polar angle of the 
tumor. The computational model is three dimensional. The governing equations and 
boundary conditions are still given by equations 2.1-2.8. Even though the model has 
changed from 2D axisymmetric to three dimensional, the equations will remain the same 
as they are in general form and can be used for any dimensional space/coordinate system. 
Figure 3.5 shows the surface temperature distribution for tumors with polar angles of 0ᵒ, 
30ᵒ and 60ᵒ. It can be seen that the region with maximum temperature moves away from 
the center as the polar angle of the tumor increases. This can be seen more clearly in 




























































































Figure 3.4: (a) Maximum temperature difference, ΔTmax,  as function of tumor size and 
depth (b) the half temperature difference length, LT, (a measure of the slope) as 




of the tumor. The polar angle of the maximum temperature location is equal to that of the 
tumor.  
Parametric variation 
The effect of blood perfusion rate and metabolic heat generation on the surface 
temperature difference (increase in surface temperature due to the presence of tumor) has 
been analyzed in figure 3.7. With increasing blood perfusion rate and metabolic heat 
generation the temperature difference increases. When the blood perfusion rate is 
quadrupled, from 0.006 sec
-1




the temperature difference at the axis 
increases from 0.4 °C to 0.8 °C. When the metabolic heat generation rate is quadrupled 
from 2500 W/m
3
 to 10000 W/m
3
 the temperature difference increases by 0.05 °C. It can 
be seen that blood perfusion rate has much more impact on the surface temperature 
distribution than the metabolic heat generation rate. It can also be concluded that the 
surface temperature is more sensitive to the variations of the blood perfusion rate than to 











3.3.2 Transient State Analysis 
                    In this section the effect of the application of cooling load, also called 
thermostimulation, and the subsequent recovery phase (thermal response when the 
cooling load is removed), is analyzed. Factors affecting the magnitude of the thermal 
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= 0.006 s-1: Q = 5000 W/m3
Figure 3.6: Surface temperature along the circumference for off-axis tumors  
  
Figure 3.7: Variation in surface temperature distribution with varying blood perfusion 




















Figure 3.8 shows the axial temperature profile during the cooling phase. The 
constant temperature boundary condition is applied for cooling and due to this the 
temperature at the surface is at 14 °C during cooling. As time progresses the temperature 
below the surface decreases with increasing cooling time. To obtain an estimate of the 
extent of the cooling, the cooling penetration depth has been defined as the maximum 
distance from the surface for which the drop in temperature is more than 0.3 °C. Figure 
3.9 shows the variation in cooling penetration depth with time. As expected, the cooling 
depth increases with increasing cooling time. 
 
Thermal recovery phase 
Axial Temperature Profile: After the cooling load is removed, the temperature gradually 
increases and over time reaches the steady state condition. Figure 3.10 shows how the 
axial temperature changes after the cooling load is removed. It can be seen that, as time 
progresses, the temperature profile approaches the steady state condition (no cooling 














































load).  The temperature of the tissue increases gradually after removing the cooling load. 
When the temperature profiles, just after removal of cooling and 50 seconds later, are 
compared, it is observed that the temperature of the region which is within 3 mm from 
the surface (towards the left of point (A)) experiences a decrease in temperature, whereas 
the deeper regions are still undergoing cooling. Similarly, when comparing temperature 
profiles at 50 seconds and 200 seconds, the region which is deeper than 6 mm is still 
undergoing cooling.  Therefore it can be concluded that there is a time lag between 
removal of cooling load and rising of the temperature in the tissue and thus the cooling 
depth keeps on increasing even after removing the cooling load.  
 
Recovery Profile: In figure 3.11 the surface temperature just above the tumor (on the 
axis) is plotted as a function of time during the thermal recovery phase for the normal and 
cancerous case. It should be noted that the plotted temperature is from the location which 
has the maximum temperature rise. The difference between the two profiles is indicated 
on the right axis. Constant temperature of 14 °C was applied during cooling, and 
therefore the recovery curve starts from 14 °C for both the cases. It can be seen that the 
difference between the two temperature profiles reaches a maximum of 0.9 °C after 10 































(η,t = 0) = 0.3 ᵒC 
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minutes, and this time will be referred to as ‘peak time’(tp). The difference gradually 
stabilizes to 0.6 °C which is the steady state temperature difference. It can be seen that 
the temperature contrast increases by 0.3 °C due to the application of cooling load.  
 
 
Effect of cooling load: In this section the effect of cooling load on the thermal recovery 
profile is analyzed. Two cooling methods are considered: constant temperature cooling 
and convective cooling. When the cooling time, for constant temperature cooling, is 
increased from 10 seconds to 80 seconds the maximum temperature difference during 









































Figure 3.10: Temperature profile along the axis during recovery after 60 s of cooling 
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recovery, Δ Tmax,recovery, increases from 0.7 °C to 0.9 °C (figure 3.12).  When the cooling 
temperature is reduced from 20 °C to 14 °C for the constant temperature cooling case the 
maximum temperature difference increases from 0.75 °C to 0.9 °C (figure 3.13). For the 
convective cooling situation the maximum temperature difference increased from 0.60 °C 
to 0.65 °C when cooling time was increased from 30 seconds to 120 seconds (figure 
3.12). When the cooling temperature is decreased from 20 °C to 14 °C for the convective 
cooling case the maximum temperature difference increases from 0.60 °C to 0.62 °C 
(figure 3.13). The increase in maximum temperature difference is more for constant 





3.3.3 Key Features to predict size and location of the tumor 
As mentioned in section 3.3.1 there are two key features of the surface 
temperature profile relevant for predicting lesion properties: maximum temperature 
difference and half temperature difference length. By using these two features it is 
possible to estimate the location and size of the tumor. It should be noted that the blood 






















































































Figure 3.12: Effect of cooling time on the maximum temperature difference 
  




perfusion rate and metabolic heat generation rate are known quantities in the analysis. 
Further, only axisymmetric case was considered.  
           It was also observed that for off-axis tumors the polar angle of the tumor can be 
determined using surface temperature profile. Using this observation and the above 
mentioned features, it is possible to extend this analysis for a general case of off-axis 
tumors.  
3.4 Conclusions 
          In the present work a 2D axisymmetric model of the breast was introduced and 
solved for temperature distribution under various conditions using FEM based 
commercial software COMSOL. The surface temperature distribution for various sizes 
and locations of axisymmetric tumors was analyzed. The behavior of off-axis tumors was 
analyzed next, and it was shown that the polar location of the tumor can be predicted 
using the surface temperature profile. The parametric analysis during steady state 
conditions predicts that the variation in surface temperature profile due to metabolic heat 
generation is negligible as compared to blood perfusion rate. 
           It is observed by means of transient analysis that the cooling depth increases even 
after removing the cooling load. The effect of cooling load on the recovery profile was 
analyzed and it was found that as the cooling time increases and cooling temperature 
decreases the highest temperature difference increases for both constant temperature 
cooling and convective cooling. Constant temperature cooling is far more effective than 
convective cooling.  
            Based on the steady state analysis two key features, maximum temperature 
difference and half temperature difference length were identified as data allowing to 
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estimate the location and size of the tumor from the surface temperature distribution. In 
this analysis metabolic heat generation and blood perfusion rate were assumed to be 
known quantities. Though the analysis was conducted for the axisymmetric case, it can 
be extended to off-axis tumors (section 3.3.1: ‘Off-axis tumors’) based on the observation 
















Inverse method for quantitative characterization of 
breast tumors from  surface temperature data 
The complete authorship of this work should be read as Rajeev Hatwar and Cila Herman. 




Inverse problems are encountered in various fields of science and engineering, we 
will be dealing here with its application in bio-medicine. In the present study, tumor 
parameters are extracted from the surface temperature distribution, as the heat is 
generated within the body from the tumors and transported in all directions. In 
thermographic (Infrared) imaging a volume heat source (increased metabolic heat 
generation and blood perfusion in the malignant tumor is compared to normal heat 
generation in healthy tissue) is located within the body. We use the bioheat transfer 
equation here to model heat transfer processes inside human tissue, and compute surface 
temperature signatures which serve as input data for the inverse reconstruction algorithm. 
Then, based on the surface temperature profile, we estimated tumor parameters.   
During the past few years, several research teams (Mital and Pidaparti 2008, 
Mitra and Balaji 2010, Bezerra et al 2013, Das and Mishra, 2013 and 2014) attempted to 
solve the inverse problem for breast cancer. Mital and Pidaparti (2008) simultaneously 
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estimated size, location and metabolic heat generation, and used Artificial Neural 
Network (ANN) and Genetic Algorithm (GA) methods on a multilayer, 2D model. 
Bezerra et al (2013) estimated thermal conductivity and blood perfusion rate using the 
Sequential Quadratic Programming method. They used a 3D surrogate geometry based on 
external breast prosthesis. Both these researchers (Mitra and Balaji (2010) and Bezerra et 
al (2013)) used a correlation for their analysis that related the diameter of the tumor with 
the metabolic heat generation rate. According to this correlation, larger tumors have 
lower metabolic heat generation rate. However, Gautherie (1980) observed that the 
metabolic heat generation rate was cancer-specific and case-specific and it was constant 
during tumor evolution. Based on his work, it can be concluded that the metabolic heat 
generation rate might not always be entirely dependent on the size of the tumor. 
Therefore, there is a need to relax this assumption inherent in the correlation used by 
Mitra and Balaji (2010) and Bezerra et al (2013). 
Mitra and Balaji (2010) used the artificial neural network (ANN) method on a 
single tissue, 3D hemispherical model to simultaneously estimate size, location and 
metabolic heat generation of the lesion. It should be noted that they have used steady 
state data for their analysis. It will be shown in the present work that it is difficult to 
simultaneously estimate three tumor parameters (dimensions, location, metabolic heat 
generation rate or blood perfusion rate) with accuracy and uniquely, based on the steady 
state data alone. We will show that, for some situations, two different tumors can exhibit 
similar surface temperature signatures, and an inverse method based on steady state data 
alone can converge into incorrect solutions. The presence of noise and uncertainty 
coming from the clinical environment and during the acquisition of the surface 
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temperature can further add to the challenge. Therefore, inclusion of additional 
information in the form of transient response makes it possible to estimate the third 
parameter uniquely. The transient response is obtained after an application of cooling 
load to the surface and then recording the recovery profile. Das and Mishra (2013, 2014) 
estimated the size and location of tumor in a 2D rectangular domain, using the genetic 
algorithm and curve fitting method. They considered breast as a uniform tissue instead of 
a multilayer structure. In 2015, Das and Mishra extended their analysis to 3D 
hemispherical domain and used curve fitting method. All these researchers have based 
their analysis on steady state temperature data. 
 Based on the literature survey conducted, a need for an inverse reconstruction 
method exists that will allow us to simultaneously and uniquely estimate size, location 
and blood perfusion rate, a measure for the metabolic activity, of the tumor based on the 
surface temperature signature. In the present work we used, the Levenberg-Marquardt 
(LM) method (Ozisik and Orlande (2000)) to uniquely and simultaneously estimate the 
above mentioned parameters.  We found that for this inverse analysis the steady state 
surface temperature was not sufficient to yield a unique solution, therefore, we added the 
transient data set to our inverse reconstruction algorithm. Transient data were generated 
by applying a cooling load and then recording the temperature as the tissue recovered 
(Pirtini Çetingül and Herman (2011), Cheng and Herman (2014)). It should be noted here 
that transient analysis has been used before (Deng and Liu 2000, Liu et al 2002) for 
inverse analysis, however it was limited to the estimation of the blood perfusion rate 
only. Kleinman and Roemer (1983) also used the transient analysis on a one-dimensional 
model to estimate the temperature distribution and blood perfusion rate beneath the 
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surface based on surface temperature data. Further, transient analysis was also used by 
Bhowmik and Repaka (2016) to estimate the geometric and thermophysical properties for 
melanoma. Although similar to our work there are major dissimilarities, among other 
things we have given an explanation for the need of transient analysis, have used initial 
guesses far away from the exact parameters, used a different optimization algorithm and 
have reduced computational time. Blood perfusion rate is a potential indicator of the 
increased cell activity in the tissue, which can be potentially related to the stage of the 
tumor (Gautherie (1980)). There are many variables involved in the accurate staging of 
the tumor and blood perfusion rate at best can be used an adjunct technique. Thus the 
transient version of the inverse method has a potential to aid in the staging of the tumor 
by estimating blood perfusion from the surface temperature signature.  
           The novelty in the present model is the combination of a more complex geometry, 
(which includes all the tissue layers with their thermophysical properties), incorporation 
of transient data and estimation of blood perfusion along with depth and size of tumor. 
One of the major advantages of the present inverse method over previously reported 
methods is that it uses transient data in addition to steady state data for the estimation of 
parameters, which resolves some issues encountered with the uniqueness of 
reconstruction based on steady state data alone. This additional set of input data improves 
the accuracy of the solution and can reduce the effect of noise in the input data therefore 
improving the robustness of the solution. The need for the transient analysis will be 
further justified in sections 4.3.2 and 4.3.3. Unlike some of the inverse methods used 
earlier (Mital and Pidaparti 2008, Mitra and Balaji 2010), this method is not statistical, 
therefore, it is more simple and intuitive. The progression of the solution can be 
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monitored, which is useful while accessing the performance and progress of the 
algorithm. Furthermore, our inverse method does not require test cases to train the 
algorithm like the statistical methods, which can prove to be an important advantage 
while applying this technique in clinical setting. The goal of our study was to develop 
inverse reconstruction software to support our portable infrared imaging system, 
therefore special attention was devoted to keeping the computational effort reasonable. 
The objective is to run the image, acquisition, processing and inverse reconstruction 
algorithms on a portable PC or laptop.   
4.2 METHODOLOGY 
The inverse reconstruction of tumor parameters based on surface temperature data 
involves several steps. In this study we use a computational phantom of the breast with 
the tumor to generate the surface temperature data for the testing of the reconstruction 
algorithm. In a clinical implementation these surface temperature data would be acquired 
by infrared imaging. The advantage of using a computational phantom to test the inverse 
reconstruction method is that the exact parameters of the tumor are known and this allows 
easy testing of the inverse reconstruction accuracy. The computational phantom also 
allows the flexibility to vary tumor properties in parametric studies. Once the inverse 
reconstruction method is extensively tested and validated, measurement data are used. 
We describe the mathematical model used to generate the computational phantom, as 
well as to solve the direct problem in Section 4.2.1. The direct problem involves 
calculation of the surface temperature distribution for a given set of system parameters 
during the iterative inverse reconstruction process. For solving the direct problem, FEM 
based commercial software COMSOL Multiphysics v 4.3 (2013) was used. The 
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Levenberg-Marquardt (LM) method was used to estimate the unknown tumor parameters 
using successive iterations and it is described in Section 4.2.2.  
4.2.1 Mathematical model 
Table 4.1: Thermophysical properties of the tissue layers in Equation (2.1) 
 
a
 Pirtini Çetingül and Herman (2011) 
b
 Ng and Sudharsan (2001) 
c
 Amri et al (2011) 
d
 Jiang et al (2011)  
The system of seven partial differential equations (2.1.1) is solved, subject to 
boundary conditions (2.1.2 – 2.1.8) using the commercial software COMSOL 
Multiphysics v 4.3 (2013). A MATLAB code was developed for solving the inverse 
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problem. While solving the inverse problem in MATLAB, COMSOL was accessed to 
compute temperature distributions for a given set of input parameters updated by the 
inverse reconstruction algorithm. For the purpose of communication and control of 
COMSOL by means of MATLAB, the LiveLink for MATLAB was used. The PC 
computer system used to run the present model was equipped with an Intel core i-7 
processor, with 3.4 GHz frequency and 32 GB RAM. A typical mesh generated for the 
computational domain contains 8,000 elements (figure 4.1 (a)). It takes about 6 seconds 
to solve the set of equations for steady state analysis and about 16 seconds for the 
transient analysis. Mesh sensitivity analysis was carried out to ensure that the change in 
temperature, due to further refinement of the mesh, was less than 0.1 %. The choice of 
the time step was governed by two factors, computational speed and accuracy. A smaller 
time step increases the accuracy but it also leads to increase in computational time. For 
the present case a time step of 2 seconds was taken as the temperature change was less 
than 0.1% after decreasing the time step. The steady state temperature distribution in the 
cancerous breast for the conditions described by equations (2.1-2.8), obtained using 




4.2.2 Input data for the inverse problem: computational phantom 
Input data for the inverse reconstruction algorithm are generated using the 
computational phantom in this study. In a clinical application computed surface 
temperature data (from the computational phantom) are replaced by measurement data 
obtained by means of infrared imaging. In the computational phantom, the tumor is 
Figure 4.1: (a) Computational mesh, (b) computed temperature distribution in the cancerous 
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modeled in COMSOL for the exact set of tumor parameters   ,    and    . The exact 
set of tumor parameters for the steady state analysis (figure 1) is stored in the vector  
    [
  
  
]     .                                                                                                             (4.1) 
The transient analysis accounts for an additional unknown parameter   , 
therefore the exact set of parameters for the transient case becomes 
    [
  
  
   
] .           (4.2) 
Computed surface temperature data, obtained solving the mathematical model 
described by equations (2.1-2.8) for tumor parameters from equations (4.1-4.2),  at I = 12 
points on the surface, corresponding to 12 angular locations (figure 4.1 (c)) 
                                                                                                                 (4.3) 
served as input values for the inverse reconstruction algorithm. Steady state temperature 
data  computed using the COMSOL model, were stored in the input vector     as  
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 The number of input data points in equation (4.4) was kept low, as a large number 
of data points would significantly increase computational effort and require advanced 
computational resources. The selected number of data points was determined by trial and 
error, and was guided by the required accuracy for the selected application. If necessary, 
the number of data points in a particular application can be increased to improve 
reconstruction accuracy. Further, the data points were distributed in the region where the 
temperature increase caused by the presence of the tumor is most pronounced, 
corresponding to the strongest measurement signal in a clinical application. In this study 
they were not distributed throughout the entire circumference, rather they were 
concentrated within a limited region (0-22° angle) relative to the z axis (figure 4.1 (c)).  
For the transient analysis surface temperature data as a function of time was also 
collected during the thermal recovery phase at times    = 200s, 400s, 500s, 600s, 700s, 
800s, 1000s. Only one surface point is considered to describe the time dependence of 
temperature, in order to strike a balance between the computational cost and accuracy. 
The selected point is located on the skin surface directly above the tumor (     
  ), and 
this is the point that records the maximum temperature rise (Chanmugam et al, 2012).  In 
the present work only a single point is taken to record the transient temperature. This was 
sufficient to get convergence for the transient case. Adding additional data points was 
increasing the size of the matrix, for each data point the rank of the matrix was increasing 
by 7, and therefore this was taxing on the computational resources. Furthermore there 
were problems with convergence after adding additional data points so we avoided 
adding additional points. 
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The vector containing the surface temperatures for the transient case consists of 
the Yss, as described by equation (4.4), followed by the transient data     
     [
   
        
 
        
]                                                                                                       (4.5) 
where  (     ) represents the temperature data during thermal recovery at time   . The 
dimension of      is 19 × 1.  
 In clinical applications the measured steady state or time dependent temperature 
will be acquired by static or dynamic infrared imaging of the breast surface temperature. 
Typical thermal signatures were analyzed computationally by Chanmugam et al. (2012). 
They showed that the temperature rise can be more than 1 ⁰C for shallow and large 
tumors. For smaller and deeper tumors the temperature rise is low, but for the majority of 
cases analyzed by the authors it was more than 0.1 ⁰C. These results suggest that modern, 
miniature, low-cost IR imagers are suitable for clinical diagnostic applications. The 
infrared imager can be combined with a 3D imager, such as the Microsoft Kinect. As 
shown by Cheng (2015), mapping 2D temperature data onto a 3D surface mesh generated 
by Kinect increases measurement accuracy and should be considered for clinical 
implementation. The geometry of the breast is not hemi-spherical and the COMSOL 
model can be adjusted to accommodate the exact shape when data are available.  
4.2.3 Inverse problem: overview 
In this section we provide a general overview and rationale of the inverse 
reconstruction method used in our study, whereas details of the mathematical 
formulations of the inverse reconstruction method are introduced in Section 4.2.4. As 
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mentioned Section 4.1, the problem of extracting the model parameters (tumor location, 
dimensions and tumor properties R, D and   ,           ) from the observable data 
(measured or computed temperature distributions,            in the present study) is 
known as the inverse problem, and its application in heat transfer is known as the inverse 
heat transfer problem (IHTP). The measured or computed surface temperature 
distributions            (equations 4.4 and 4.5) as well as the initial guesses of the model 
parameters R, D and     (their exact values are to be determined by inverse 
reconstruction) provide the input data.   
           IHTP problems are very sensitive to the changes in the input data to the model and 
therefore are classified as ill-posed problems (Ozisik and Orlande (2000)). To overcome 
the ill-posedness of the problem, regularization methods and other least square 
minimization methods are used. In the current work, the Levenberg-Marquardt (LM) 
method is implemented.  In the LM method, the difference between experimental and 
calculated data is expressed in the form of the sum of squares S. The geometrical and 
thermophysical characteristics of the tumor, such as size, location and blood perfusion 
rate, R, D and   , are adjusted iteratively, and the computed surface temperature 
response is compared to the measured or computed (using the phantom, Sections 4.2.1 
and 4.2.2) temperature data to minimize S. In order to counter the ill-posed nature of the 
problem, the LM method uses a damping factor.  
          The LM method iteratively solves for the tumor parameters R, D and    and 
computes surface temperature distributions for each iteration. The iterative process 
continues until the difference between measured and computed surface temperatures S 
falls below a certain value and satisfies the stopping criterion.  
63 
 
4.2.4 Inverse algorithm  
The algorithm used to solve the inverse problem is illustrated in figures 4.2 and 4.3. The 
flowchart of the general algorithm is displayed in figure 4.2, and details of the LM 
regularization portion of the algorithm are provided in figure 4.3. Each block of the 
algorithm is identified by a letter and the blocks are referred to by figure number and 
letter in the text. For example, figure 4.2 (a) refers to block (a) in figure 4.2.  It should be 
noted that the variables for steady state and transient state, though they have the same 
generic form, differ due to the presence of the additional parameter ωb and additional 
transient data. These differences are described in the text and steady state and transient 
variables are referred to by their generic form, whenever admissible. For example, in 
figures 4.2 and 4.3 only the generic forms of these variables are used.  
Input data, initial guesses and process variables                                                             
The algorithm begins with an initial guess for the set of unknown parameters R, D and 
   stored in the vector  
  (figure 4.2 (c)) as 
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]    for steady state (figure 4.2 (a)) and                                                    (4.6)                                                       






]     for the transient analysis (figure 4.2(b)).                                        (4.7) 
The algorithm proceeds from the initial guesses to improved estimates of 
unknown parameters iteratively, using LM method. The set of unknown parameters at the 
m
th
 iteration is represented by the vector      as 
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Figure 4.2: Flowchart of the inverse reconstruction algorithm 
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Figure 4.3: Flowchart describing block (j) in figure 4.2 
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]            for transient analysis.                                                                 (4.9)                                                                                    
The surface temperatures corresponding to the set of parameters    for the 
steady state analysis are stored in the vector       as 
     






        
 
          
 





                                                                              (4.10) 
In transient analysis,       also contains surface temperature data obtained 
during the thermal recovery phase corresponding to      at different times tj (j = 1, 2, 
…. k ), similar to the vector Ytr  described in section 4.2.2.         is described as  
     
    [
     
        
 
        
] .                                                                                          (4.11) 
The measured temperature  , discussed in Section 4.2.2 (equations 4.4 and 4.5), is 
the second set of input data required by the algorithm (figure 4.2 (d)). The third input 
parameter used by the algorithm is the damping factor   (figure 4.2 (e)). The value of     
is taken to be   = 0.1 for the steady state analysis with two unknowns and the initial  
guess is   = 0.01 for transient analysis and the steady state analysis with three unknowns. 
The parameter    is used in the LM method and it is analogous to the relaxation factor. 
The role of    is explained in more detail in section 4.2.4.3. 
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The commercial finite element code COMSOL is used to solve the direct problem 
(figure 4.2 (f)) of evaluating the surface temperature profile       (figure 4.2 (g)) for 
each iteration m.  
Main algorithm 
The goal of the iterative procedure is to let     and therefore       To this end we 
define the objective function      (figure 4.2 (h)), the sum of squared errors, as (Ozisik 
and Orlande (2000))  
      [       ]  [       ]   .                                                                 (4.12) 
      is a measure of the difference between the measured/computed temperature  
profile   and the one obtained during the inverse reconstruction process based on 
iteratively defined tumor parameters,       (figure 4.2 (g)). The form of the vectors 
     and      is defined by equations (4.4), (4.8) and (4.10) for the steady state analysis 
and equations (4.5), (4.9) and (4.11) for the transient analysis. The set of tumor 
parameters    is accepted as the final estimate if the objective function,     , falls 
below a pre-defined value   as 
               .                                                                                               (4.13) 
Equation (4.13) is referred to as the stopping criterion (figure 4.2 (i)), and once it is met 
the algorithm stops (figure 4.2 (l)) with the accepted set of tumor parameters      . 
If the stopping criterion is not met, the set of parameters    is fed into the inverse 
method along with the current damping factor   (figures 4.2 (j) and 4.3 (a)) to find the 
next estimate of the unknown parameters      and damping factor       (figure 4.2 
(k)). The next estimate (m+1) is fed into the direct problem (figure 4.2 (k) and (f)). This 
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iterative cycle continues until the stopping criterion is met and the set of parameters 
hence obtained is accepted as the final estimate (figure 4.2 (l)). 
Improving the estimates: LM algorithm 
The details of the algorithm used in the “inverse method” part of figure 4.2 (j) are 
illustrated in figure 4.3. The objective of this part, the LM algorithm, is to take a set of 
tumor parameters    , either the initial guess or the improved values determined through 
the iterative process, as input (figure 4.3 (a)) and compute an improved estimate of tumor 
parameters      as the output (figure 4.3 (l)).  
Based on the input parameters     and      , the sensitivity matrix       is 
calculated first (figure 4.3 (b)). The sensitivity matrix accounts for the variation of 
surface temperature in response to the change of the tumor parameters  ,   and  .  For 
the steady state analysis the sensitivity matrix is defined as 
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  ,                                                                      (4.14) 
where   is the total number of temperature measurements on the surface (12 in this 
study). In the sensitivity matrix an element located at i
th
 column and j
th
 row describes the 
variation of surface temperature at j
th
 location with respect to parameter Pi.      
   in 
equation (4.14) is a 12×2 matrix, as we have 2 unknown parameters, R and D, and 12 
measurement points.  
Individual elements of the sensitivity matrix are calculated using the approximation 
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The term     in equation (4.15) is defined as  
       [
    
 
]  and        [
 
    
]   
for the steady state analysis.   
    in equation (4.15) is a pre-defined, fixed increment for the tumor parameters 
R and D,    =  [0.2 mm, 0.2 mm ] .   The sensitivity matrix for the transient case is 
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] 
for  times    during thermal recovery t :{200s, 400s, 500s, 600s, 700s, 800s, 1000s }. 
Elements of the sensitivity matrix for the transient situation are also determined using 
equation (4.15).  For the transient case the term     in equation (4.15) is defined as 
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]  ,        [
 
    
  
]  and       [
 
 
      
]   .               (4.17) 
The dimensions of the sensitivity matrix       
    are 3 × 19, larger than for steady state 
(equation (4.14)), because of the additional unknown parameter ωb and the difference in 
the  expressions for       (equations (4.10) and (4.12)). Since the increment vector    
for the transient case has an additional element accounting for ωb, it takes the form    = 
[0.2 mm, 0.2 mm, 0.0001 ml/sec/ml]. Different values of    were tried and tested. The 
value used in the present work where giving the best results, in terms of convergence and 
computational time, and therefore were chosen. 
After determining the sensitivity matrix, the LM  method (figure 4.3 (c)) is used 
to calculate the next set of parameters      is (figure 4.3 (d)) 
        ⌊             ⌋        [       ]                                    (4.18) 
where     diag ⌊         ⌋    .                                                                                               
In equation (4.18)   represents the current iteration step and    is the 
corresponding damping factor.  As the damping factor is increased, the algorithm 
becomes more stable at the expense of speed. The damping factor controls the difference 
between    and probable    ; the larger    is, the smaller will be the difference 
between tumor parameters in successive iterations, thereby making the algorithm slower. 
Furthermore, the term ‘diag’ in equation (4.18) refers to a diagonal matrix comprised of 
the diagonal elements of the corresponding matrix. 
The next set of parameters      hence obtained is checked (figure 4.3 (e)): if one 
of the parameters is negative, they are discarded and the LM method is used again 
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(figures 4.3 (c) and 4.3 (d)) after increasing damping factor    by a factor of √  
 
 (figure 
4.3 (f)). The resulting set of parameters is checked again (figure 4.3 (e)) and this cycle 
continues until the algorithm yields a set of realistic (positive) parameters. Based on the 
new set of parameters      the direct problem is solved (figure 4.3 (g, h)) and the 
corresponding objective function         (equation (4.14)) is calculated. This new 
parameter     is accepted only when the corresponding objective function         is 
less than the one associated with the previous input parameter set    (figure 4.3 (i)) 
              .                                                                                                  (4.19)       
If this condition is met, the damping factor is decreased by a factor of √  
 
 (figure 4.3 
(k)) and the new set of parameters      is accepted (figure 4.3 (l)). On the other hand if 
the objective function is larger, the set of parameters is discarded and the damping factor 
is increased by a factor of √  
 
 (figure 4.3 (j)). Then LM method is used again to obtain a 
new set of parameters (figure 4.3 (c)). This process continues until a set of parameters is 
obtained which is better than the set of parameters from the previous iteration, in terms of 
objective function (equation (4.12)). 
4.3 RESULTS AND DISCUSSION 
In Section 4.3.1 we introduce inverse reconstruction results for steady state analysis. We 
demonstrate that the steady state analysis has some inherent limitations, and we analyze 
these in Section 4.3.2. Finally, in Section 4.3.3, we show how to overcome these 




           In the present study only those tumors were considered which were capable of 
giving a detectable temperature rise on the skin surface. Figure 4.4 shows the temperature 
rise, at skin surface directly above the tumor, for different combinations of radius R, 
depth D and blood perfusion   . The closer the tumor is to the surface and the larger its 
diameter is, the larger is the rise in the surface temperature.  
4.3.1  Steady state analysis with two unknowns (  and ) 
Tumor size (R, radius) and location (D, depth) are the unknown parameters in the inverse 
reconstruction method based on steady state surface temperature data. The 
thermophysical properties, thermal conductivity, density, heat capacity, blood perfusion 
rate and metabolic heat generation rate of the tumor are assumed to be known, and values 
used in our calculations are summarized in Table 4.1. A    10 mm deep tumor of    5 
mm radius was modeled in FEM based commercial software COMSOL. Surface 
temperature distribution was computed using COMSOL and temperature data were then 
fed into the inverse reconstruction algorithm as measured temperatures    and along with 
the initial guesses    and    for  the unknown tumor parameters R and D and damping 
factor.  
To examine the performance of our method, the inverse reconstruction algorithm 
was employed for three initial guesses    
  (equation 4.6), labeled as cases 1, 2 and 3 in 
table 4.2. Figure 4.5 shows the progression of parameters R and D from the initial guesses 
to the exact values through the iteration process. The iterations shown in the abscissa of 
figure 4.5, represent the outer loop of the algorithm, displayed in figure 4.2. Each new 
iteration corresponds to a value of S smaller than in the previous iteration. Iterations 




parameter set      is estimated, are not shown. For example, for case 1, R and D started 
with an initial guess of 8 mm and 18 mm, respectively, and they converged to the exact 
values in 6 iterations (figures 4.5 (a) and (b)). The convergence trends are similar for 







Figure 4.4: Temperature rise    at a point directly above the tumor corresponding 
to     
  as a function of tumor radius R and depth D for blood perfusion values 
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was the slowest to converge, within 13 iterations. Figure 4.5 (c) illustrates the variation of 
the objective function   during the iterative process for the three cases in table 4.2. The 
iterations stopped when the objective function reached a value that was less than the 
stopping criterion ε (10
-5
). It is evident from these results that the solution converged to 
exact values within a reasonable number of iterations for very different initial guesses. 
Therefore we can conclude that the selected inverse reconstruction method based on 
steady state data is suitable for the reconstruction of the two geometrical parameters of 
the tumor. 
4.3.2 Limitations of the steady state analysis 
In section 4.3.1 steady state data were used to reconstruct two unknown tumor parameters 
D and R.  In this section we add a third unknown parameter, the blood perfusion rate ωb, 
to the set of unknown tumor parameters, and evaluate the feasibility of simultaneously 
reconstructing all three parameters from steady state data. The exact values of the tumor 
parameters for the steady state analysis and the three initial guesses are shown in Table 
4.3. Figure 4.6 illustrates the progression of the parameters from the initial guess to the 
final solution. Final solutions along with the corresponding errors are shown in table 4.3. 
For all three cases, the iteratively computed solution progressed away from exact 
solution. Cases 1 and 2 exhibit large errors, especially for the estimates of ωb, 83.3% and 
40% respectively. For case 3 the error was smaller, with a maximum error of 7% for   . 
The smaller error for case 3 can be attributed to the initial guess being very close to the 
exact solution.  
 This behavior of the inverse reconstruction algorithm can be explained by 
considering the results in figure 4.7, which compares the surface temperature profiles of 
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the three tumors. The temperature plotted in figure 4.7 is the temperature rise due to the 
presence of tumor. The temperature difference calculated by subtracting the surface 
temperature of the healthy breast from the temperature of the cancerous breast. One of 
the three surface temperature profiles in figure 4.7 correspond to the exact set of 
parameters (†) given in table 4.3. The remaining two show the converged, but incorrect, 
solutions of cases 1 and 2 marked by * in table 4.3. In spite of the marked difference in 
the tumor parameter values D, R and ωb, the three tumors yield almost identical surface 
temperature profiles, close enough to satisfy the stopping criterion (equation 4.13). These 
results suggest that different combinations of D, R and ωb can yield nearly identical 
thermal signatures, i.e. the thermal signatures of the tumor are not unique.  Therefore, 
during the iterative revisions of the parameter set, the inverse algorithm converged to an 
incorrect solution. The reduction in surface temperature due to smaller tumor size for the 
final solution of case 1 is compensated by lower depth and a higher blood perfusion rate 
of the other tumors. 
Table 4.2: Exact tumor parameters D and R and three sets of initial guesses (cases 1, 2 








Exact 10 5 
Case 1 18 8 
Case 2 21 11 
Case 3 15 2 
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  Figure 4.5: Evolution of (a) depth   and (b) radius   of the tumor and (c) error      




Table 4.3: Exact parameter values and three sets of initial guesses for the inverse 
problem with 3 unknowns for steady state analysis. Temperature rise for sets of 








Blood Perfusion rate, 






     
 Exact *† 11 7 0.003 
     
Case 1 Initial 9 5 0.001 
 Final * 10.15 5.8 0.0055 
 Error (%) 7.7 17.1 83.3 
     
Case 2 Initial 13 8 0.002 
 Final * 12 8.3 0.0018 
 Error (%) 9.1 18.6 40 
     
Case 3 Initial 11.5 6.5 0.0025 
 Final 10.9 6.8 0.0032 
 Error (%) 0.91 2.9 6.67 
 
           The analysis in section 4.3.1 demonstrates that, based on the steady state analysis, 
it was possible to estimate the location and the size of the tumor. However, the results in 
section 4.3.2 indicate that it is not possible to estimate the third parameter ωb. When the 
blood perfusion rate is included along with size and location as unknown, the inverse 
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problem based on steady state analysis converges to the wrong solutions. Since different 








  Figure 4.6: Evolution of (a) depth D (b) radius R (c) blood perfusion rate ω
b
 of the 
tumor  and the (d) error      versus  the number of iterations using steady state 
data for the three cases in table 4.3.  
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algorithm is unable to distinguish between them. This implies that the solution for this 
inverse problem with three unknowns is not unique, even though the algorithm yields a 
unique solution for two unknowns. In clinical applications, the presence of noise, can 
further accentuate the problem.    
 
4.3.3 Solution: transient analysis 
To overcome the non-uniqueness problem and solve this inverse problem in a robust 
manner, we incorporated the transient response in the input data. The transient response 
has been used in prior studies by Pirtini and Herman (2011) for melanoma detection, 
Cheng and Herman (2014) for the analysis of near surface lesions and Bhargava et 
al.(2014) for deep tissue injury. The imaging technique employed in these studies is 
known as dynamic infrared imaging, and it is explained in section 4.2.1 (equation 2.8). In 
Figure 4.7: Surface temperature profiles for tumor parameters marked by * in 
table 2.3.3. 
  
Distance along the circumference,   [mm] 
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dynamic IR imaging a cooling load is applied on the surface for a certain amount of time. 
Then the cooling load is removed and the surface temperature is allowed to recover. The 
temperature measured during the thermal recovery process is used along with steady state 
temperature distribution to quantitatively assess lesions.  
          In order to compare surface temperatures generated by different tumors, first, the 
temperature of a cancerous breast was computed during the thermal recovery process, at a 
point located on the skin surface and on the axis, directly above the tumor. The reason for 
picking this particular point has been explained in section 4.2.2. Then the temperature of 
a healthy breast at the same location is subtracted from it, resulting in a temperature 
difference. In figure 4.8 this temperature difference is plotted against time, for the three 
tumors considered in the steady-state analysis. These are the same three tumors marked 
by “an asterisk” in table 4.3, which resulted in identical steady state surface temperature 
profiles (figure 4.7). It can be seen that the transient thermal recovery temperature profile 
is different for the three cases. Therefore the inverse reconstruction algorithm should not 
get trapped into incorrect solutions when transient data are included in the analysis. This 
approach makes it possible to estimate the blood perfusion rate along with the size and 
location of the tumor uniquely.   
4.3.3.1 Transient analysis with three unknowns 
         To illustrate the use of transient response in inverse reconstruction we considered 
the same set of exact parameters     (equation 4.2) and initial guesses     (equation 4.5) 
as for the steady state analysis (table 4.3) and added the transient data. A detailed 
description of the input parameters for the transient case is found in section 4.2.2. Figure 
4.9 illustrates the progression of the solution from the initial guess to the converged 
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solution for  ,   and   . The error for each iteration is shown in figure 4.9 (d). The 
solution converged to the correct solution for all three initial guesses, with negligible 
errors (Table 4.4). Case 1 took the highest number of iterations to converge (34) and case 
3 the least number of iterations (8). Since the blood perfusion rate is an indicator of the 
metabolic activity of the tumor, it can help estimate the stage of the tumor and therefore it 
is an important tumor parameter of interest in clinical applications. Further the use of 
additional set of input data improves the accuracy of the solution and can reduce the 
effect of noise in the input data therefore improving the robustness of the solution. In the 
transient analysis temperatures were recorded at intervals of more than 100 s and this 
makes sure that it is easily within the temporal resolution of IR cameras, which is less 
than a sec. 
 
Figure 4.8: Thermal recovery temperature profile of a point directly above the tumor 
corresponding to   . The tumors considered are the 3 tumors marked by * in table 4.3 




Several other cases were tried with different set of exact parameters and are listed in 
table 4.4. Different initial guesses were tried, including those which were far away from 
the exact parameters. The test cases considered here have tumors ranging from 12 mm to 
30 mm in depth, 7 mm to 11 mm in radii and blood perfusion rate ranging from 0.003 1/s 
to 0.01 1/s. The error in the solution was low for near surface tumors and it increased 
with increasing depths. It was observed that tumors with 0.01 1/s blood perfusion rate and 
11 mm radii gave errors of less than 1 % when they are within 20 mm from the body 
surface. Even though shallower tumors in Table 4.5 have blood perfusion rates lower 
than 0.01 1/s and hence lower rise in surface temperature (figure 4.4), they were giving 
low errors. Errors in blood perfusion rate were particularly large for deeper tumors, this 
can be explained by the fact that surface temperature becomes increasingly insensitive to 
the blood perfusion rates for deeper tissue layers (Kleinman and Roemer 1983). Further 
smaller tumors will be giving lower temperature signals, but it is the larger tumors which 
have been associated with lower survival (Carter et al. 1989). Different initial guesses 
were tried, including those which were far away from the exact parameters. The test cases 
dealt in here had tumors and then an estimate for their parameters was obtained. In the 
case of no tumor, it is expected that the algorithm will converge to a solution indicating 
no tumor. The solution will start from the initial guess for tumors and will eventually 
converge to zero radii and/or maximum depth and/or blood perfusion rate equal to the 
surrounding healthy tissue. 
 The ability gained by this novel approach to estimate the blood perfusion 
rate is very critical. MRI, mammography and other non-invasive modalities can identify 
the location and size of the tumor, but it is difficult to ascertain the level of malignancy of 
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the tumor based on these tumor parameters. The diagnosis of cancer might require 
multiple visits to the clinic, before a biopsy (definitive test), for determination of tumor 
malignancy. On the other hand, an estimate of blood perfusion rate can give an 
unequivocal indication of tumor malignancy, as there is a direct correlation between 
tumor growth rate and tumor malignancy. Therefore, this approach has the potential to 
reduce the time, cost and effort involved in tumor detection.  
Even though this approach, in its present format, does not give accurate result for 
deeper tumors, it can be modified to give critical diagnostic and staging information. CT 
scans can be used to determine the location and size of the tumor and this information can 
then be potentially utilized to increase the accuracy of the blood perfusion rate 
estimation. Blood perfusion rate in turn can help in staging of the tumor, which is very 
critical in determining the cancer treatment strategy.  
It should be noted that MRI can also be used to estimate blood perfusion. MRI 
can give the blood perfusion distribution within the tissue and it can prove beneficial for 
diagnosing and characterizing tumors. Thermography has an edge over MRI as it is much 
more economical and completely non-invasive. An MRI system is very expensive and 
requires a dedicated room or hardware (or large trailers for mobile systems) and a highly 
trained operator. A thermographic imaging system costs orders of magnitude less, is 
orders of magnitude smaller and can operated by existing clinical staff after basic 
training. It is suitable for screening and telemedicine applications. Additionally for MRI 
perfusion measurements, contrast agent has to be injected into the subject’s body. 
Thermographic test can be 10 times cheaper and the equipment cost can be 100 times 












Figure 4.9: Evolution of (a) depth D (b) radius R (c) blood perfusion rate    of the 
tumor and (d) error S(P) vs the number of iterations using transient data for the three 




Table 4.4: Exact parameter values and three sets of initial guesses for the inverse 








Blood Perfusion rate, 






     
 Exact 12 10 0.003 
Case 1 Initial 10 8 0.002 
 Final 12 10 0.003 
 Error (%) 0.053 0.05 0 
     
 Exact 13 10 0.004 
Case 1 Initial 12 9 0.003 
 Final 13 10 0.004 
 Error (%) 0 0.001 0 
Case 2 Initial 10 9 0.003 
 Final 13 10 0.004 
 Error (%) 0 0.009 0 
Case 3 Initial 12 7 0.003 
 Final 13 10 0.004 
 Error (%) 0 0.015 0 
Case 4 Initial 10 8 0.005 
 Final 13 10 0.004 
 Error (%) 0 0.008 0 
     
 Exact 14 10 0.0045 
Case 1 Initial 13 11 0.004 
 Final 14 10 0.0045 
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 Error (%) 0.03 0.068 0 
Case 2 Initial 12 9 0.003 
 Final 14 10 0.0045 
 Error (%) 0.022 0.082 0 
Case 3 Initial 11 8 0.0035 
 Final 14 10 0.0045 
 Error (%) 0.02 0.073 0 
Case 4 Initial 16 8 0.0025 
 Final 14 10 0.0045 
 Error (%) 0.014 0.055 0 
Case 5 Initial 10 7 0.002 
 Final 14 10 0.0045 
 Error (%) 0.014 0.055 0 
Case 6 Initial 8 4 0.001 
 Final 14 10 0.0045 
 Error (%) 0.021 0.074 0 
Case 7 Initial 21 6 0.003 
 Final 14 10 0.0045 
 Error (%) 0.03 0.097 0 
     
 Exact 16 11 0.0055 
Case 1 Initial 14 9 0.002 
 Final 16 11 0.0055 
 Error (%) 0.002 0.014 0 
Case 2 Initial 12 7 0.002 
 Final 16 11 0.0055 
 Error (%) 0.001 0.006 0 
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 Exact 15 11 0.01 
Case 1 Initial 13 9 0.008 
 Final 15 11 0.010 
 Error (%) 0.013 0.035 0 
Case 2 Initial 12 8 0.007 
 Final 15 11 0.01 
 Error (%) 0.001 0.006 0 
Case 3 Initial 18 8 0.005 
 Final 15 11 0.01 
 Error (%) 0.015 0.042 0 
     
 Exact 20 11 0.01 
Case 1 Initial 22 9 0.007 
 Final 20.02 10.90 0.0108 
 Error (%) 0.1 0.91 8 
     
 Exact 25 11 0.01 
Case 1 Initial 23 9 0.008 
 Final 25.07 10.53 0.015 
 Error (%) 0.28 4.27 50 
Case 2 Initial 20 9 0.007 
 Final 25.10 10.50 0.0157 
 Error (%) 0.4 4.54 57 
     
 Exact 30 11 0.01 
Case 1 Initial 28 9 0.008 
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 Final 29.71 10.15 0.0181 
 Error (%) 0.97 7.73 81 
Case 2 Initial 27 8 0.008 
 Final 29.96 9.8 0.0319 
 Error (%) 0.13 10.91 219 
Case 3 Initial 26 7 0.007 
 Final 29.59 9.51 0.0332 
 Error (%) 1.37 13.55 232 
Case 4 Initial 20 6 0.005 
 Final 30.23 9.44 0.0637 
 Error (%) 0.77 14.18 537 
  
4.3.3.2 Noise analysis 
The IR cameras available presently have temporal and spatial resolution of 10 mK 
and 0.05 mm respectively or better (Çetingül M P 2010), as mentioned in section 3.3.1. 
Although it should be noted that spatial resolution is not a property of the camera and for 
a certain sensor size it will depend on the distance of the camera from the object. The 
points on the body surface, at which the temperatures are measured (Figure 2.2 (c)), are at 
a distance of 5 mm from each other and the spatial resolution of the IR cameras, at 0.05 
mm, is well above this, so they can easily capture the spatio-temperature variation.  
For thermal resolution, an analysis has been done here to show the limitations 
when noise corresponding to 10 mK is present in temperature measurement. A random 
noise of 10 mK was generated in the temperature data using a MATLAB function. For 
the noise analysis the stopping criteria (equation 4.13) was relaxed by increasing   to 
      . This particular stopping criteria was chosen based on multiple runs for different 
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cases and selecting an   which will lead to convergence for maximum cases. The results 
hence generated have been tabulated in Table 4.5. The set of exact parameters have been 
taken from Table 4.4 and corresponding initial guesses are a subset of the cases 
investigated before in Table 4.4. It was made sure that the subset of the initial guesses 
had cases which were farther away from the exact set of parameters and therefore most 
challenging. As expected the errors associated with the final solution are larger here due 
to the presence of noise and a relaxed stopping criterion, as compared to the earlier case 
(Table 4.4). Here again the error increased with increasing depth of the tumor and the 
errors in blood perfusion estimates were particularly high for deep tumors. 
4.3.4 Computational time 
The time taken by this algorithm can vary from 10 min to 50 min depending on the 
number of iterations required for convergence. In general, the further the initial guess 
from the actual solution the larger the number of iterations will be as can be seen from 
figures 4.5 and 4.9.  It takes around 75 seconds for one iteration loop as shown in the 
flowchart corresponding to the outer loop (figure 4.2 ), if the next set of parameters 
(figure 4.3 , block (d)) obtained using equation 4.18 is realistic (figure 4.3 , block (e)) and 
is a better estimate than the previous one (figure 4.3 , block (i)). If the estimate is 
unrealistic (figure 4.3, block (e)) it takes a couple of seconds to correct it and if it needs 
to be improved (figure 4.3, block (i)) it takes an extra 20 seconds for each loop. 
4.3.5 Future work 
       Several improvements can be incorporated into the existing model in the future. 
First, the Levenberg-Marquardt algorithm can be modified to improve the robustness and 
speed. In the present work, only the last iteration parameters were saved and checked for  
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Table 4.5: Exact parameter values and three sets of initial guesses for the inverse 









Blood Perfusion rate, 






     
 Exact 11 7 0.003 
Case 2 Initial 13 8 0.002 
 Final 11.09 7.13 0.0029 
 Error (%) 0.82 1.86 3.33 
Case 3 Initial 11.5 6.5 0.0025 
 Final 11.02 7 0.003 
 Error (%) 0.18 0 0 
     
 Exact 12 10 0.003 
Case 1 Initial 10 8 0.002 
 Final 11.97 9.97 0.003 
 Error (%) 0.25 0.3 0 
     
 Exact 13 10 0.004 
Case 2 Initial 10 9 0.003 
 Final 13.02 10 0.004 
 Error (%) 0.15 0 0 
Case 4 Initial 10 8 0.005 
 Final 13 9.99 0.004 
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 Error (%) 0 0.1 0 
     
 Exact 14 10 0.0045 
Case 7 Initial 21 6 0.003 
 Final 13.89 9.88 0.0046 
 Error (%) 0.79 1.2 2.22 
     
 Exact 16 11 0.0055 
Case 1 Initial 14 9 0.002 
 Final 16.01 8.91 1.82 
 Error (%) 0.063 8.91 1.82 
     
 Exact 15 11 0.01 
Case 1 Initial 13 9 0.008 
 Final 15.01 10.98 0.0102 
 Error (%) 0.07 0.18 2 
Case 2 Initial 12 8 0.007 
 Final 14.99 10.98 0.0102 
 Error (%) 0.07 0.18 2 
Case 3 Initial 18 8 0.005 
 Final 15.06 11.06 0.0098 
 Error (%) 0.4 0.55 2 
     
 Exact 20 11 0.01 
Case 1 Initial 22 9 0.007 
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 Final 19.57 10.66 0.0101 
 Error (%) 2.15 3.09 1 
     
 Exact 25 11 0.01 
Case 1 Initial 23 9 0.008 
 Final 24.42 10 0.0155 
 Error (%) 2.32 9.09 55 
Case 2 Initial 20 9 0.007 
 Final 24.57 10.3 0.0132 
 Error (%) 1.72 6.37 32 
     
 Exact 30 11 0.01 
Case 1 Initial 28 9 0.008 
 Final 27.3 9.4 0.0104 
 Error (%) 9 14.55 4 
Case 2 Initial 27 8 0.008 
 Final 26.33 8.59 0.0116 
 Error (%) 12.23 21.91 16 
Case 3 Initial 26 7 0.007 
 Final 26.89 8.54 0.0176 
 Error (%) 10.37 22.36 76 
Case 4 Initial 20 6 0.005 
 Final 27.27 8.35 0.03 




improvement in the solution. This can be increased to two or three previous iterations, 
this might lead to increase in robustness of the algorithm. Further the placement of the 
data points on the surface and the time points during recovery phase can be varied to 
reduce the computational time. Second, a 3D model of the breast can be used to include 
tumors which are not centered along the axis. With the current version of COMSOL 
Livelink with MATLAB, it was not possible to iteratively change the location and 
dimension of tumor for a 3D model. So there is a need to use different software or to 
develop an indigenous code. Third, the variation in thermophysical properties with 
temperature can be included in the model to make it more accurate. For example, blood 
perfusion rate is dependent on temperature and due to application of cooling load there is 
going to be variations in temperature within the body tissue. Finally, a sensitivity analysis 
can be done to quantify the effect of uncertainties of the parameters involved.   
4.4 CONCLUSIONS  
In the present work we used an inverse reconstruction method, based on the 
Levenberg-Marquardt algorithm, to characterize a tumor based on the skin surface 
temperature. This method was applied for two different cases. The first case relied on 
steady state surface temperature data as input. Tumor location and size were the unknown 
parameters, and the thermophysical properties of the tumor and healthy tissue were 
considered to be known. In the second case transient data served as input along with 
steady state data, and the blood perfusion rate of the tumor was added to the unknown 




         The first case, that uses the surface temperature profile at steady state, has some 
limitations. Though it can uniquely estimate size and location of the tumor based on 
steady state data, problem arises when an additional tumor parameter, blood perfusion 
rate, is added as an unknown. Noise in the input data can further accentuate the problem. 
In order to correctly and uniquely estimate the size, location and blood perfusion rate of 
the tumor simultaneously, we used transient analysis in the second case. For deeper 
tumors the solution seems to converge away from the exact set of parameters.  
To summarize, addition of transient data with steady state data allows simultaneous 
estimation of blood perfusion rate, size and location of tumor, which is not possible with 
steady state data alone. Although this has limitations, but when combined with other 











Chapter 5  
CT Perfusion Imaging 
The complete authorship of this work should be read as Rajeev Hatwar, Prof. Eleni Liapi 
and Prof. Robert Ivkov. The experiments were performed by Prof. Eleni Liapi.  
 
5.1 INTRODUCTION 
In computed X-ray tomography (CT) imaging, multiple images are taken at different 
angles to produce cross sectional images of the scanned object. A variation of this 
technique, CT perfusion imaging, allows the user to analyze the hemodynamics within 
the region of interest (Miles and Griffiths 2003, Kim et al. 2014). In this technique a 
contrast agent, which is opaque to x-rays, is injected intravenously. This is followed by a 
series of scans to trace the movement of the contrast agent within the target tissue. 
Images from these scans are then processed to obtain the information related to the flow 
of the contrast agent and thereby blood flow. 
The knowledge of blood flow within a given tissue can prove beneficial for 
diagnostic purposes. Blood flow measurements can help in differentiating between 
normal and malignant tissue, further it can also give information about the necrotic 
regions present within a tumor (Miles et al. 2000, Miles 1999). The benefits of CT 
perfusion go beyond diagnosis as it can also be used for estimation of response to therapy 
and for treatment planning. Brain and liver are some of the most common applications of 
CT perfusion imaging. Interventional radiologists largely identify malignancy in a given 
liver tissue using the blood flow measurements of hepatic artery and portal vein, two 
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sources of blood supply for the liver (Pandharipande et al. 2005, Kim et al. 2014). 
Further, as seen in the previous section, blood perfusion is a dominant factor governing 
the temperature distribution within a tissue. Therefore, a precise knowledge of the blood 
perfusion distribution within a tissue is critical for modeling heat flow within the body 
tissue. All these factors make CT perfusion an important component for effective 
diagnosis and treatment planning. 
There are different variations of CT scanners available commercially, some of the 
widely used scanners are listed in table 5.1. 
Table 5.1 Commercially available CT scanners 
Scanner Name Manufacturer 
64- row multidetector 
CT scanner 
VCT GE Healthcare 
4-MDCT scanner Lightspeed Plus GE Healthcare 
16-MDCT scanner LightSpeed GE Healthcare 
16-detector row scanner Lightspeed 16 GE Medical Systems 
Multi-detector row 
CT scanner 
Sensation 16 Siemens medical solutions 
 
 X-ray CT enables non-invasive blood perfusion measurements, although imaging 
protocols and methods to calculate blood perfusion from acquired imaging data are still 
under development (Kim et al. 2014, Materne et al. 2000, Meier and Zierler 1954, Miles 
et al. 1991). The contrast concentration within a tissue increases as the blood brings the 
contrast material into the tissue. It subsequently decreases due to the removal of contrast 
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material from the tissue by venous outflow. Meier and Zierler have given a basic 
description of extracting blood perfusion and other perfusion parameters from the time 
varying contrast concentration in tissue (Meier and Zierler 1954). Over the time methods 
for calculating blood perfusion have evolved (Kim et al. 2014). Some of the most 
prevalent are the maximum slope method (Miles 1991, Miles et al.1991, Miles et 
al.1993), tracer kinetic method  (Tofts et al.1999, Sourbron and Buckley 2011, 2013, 
Swinton et al.1970) and de-convolution method (Axel 1980, Axel 1983, Cuenod et 
al.2001).  
     The field of estimation of blood flow, volume using dye injection, indicator-
dilution technique, started with Stewart (1897) and was further developed by Hamilton et 
al.(1932). During the later years there was confusion regarding this method and a detailed 
analysis of this was presented by Meier and Zierler (1954) and Zierler (1962).  
Earlier studies used radio-isotopes as indicators (Sapirstein 1958, Zierler 1965) for 
blood flow estimation. Mathematical analysis of the flow of injected dye/contrast 
material in capillary beds has also been performed (Leonard and Jorgensen 1974, 
Borovetz et al. 1982, Lincoff et al. 1983). Fleming et al. used radiocolloid for estimating 
arterial and portal blood supplies for liver (Fleming et al. 1983). Mullani and Gould 
proposed a simple model for blood flow measurement where there is no venous outflow 
for some period before the start of recirculation (Mulani and Gould 1983). Patlak plot 
(Patlak et al. 1983 and Patlak and Blasberg 1985) was later developed which did not 
required compartmental models but required that concentration agent concentration has 
reached equilibrium within the tissue and plasma. This model has the flexibility to be 
used with homogenous as well as heterogeneous tissue and was applied to cerebral blood 
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flow by Patlak et al.. Rumberger et al. (1987) reported the calculations of the myocardial 
perfusion using contrast agent concentration curves obtained from CT scans and 
compared it with measurements from radiolabelled microspheres. Canine myocardial 
blood flow measurements were reported by Wolfkiel et al. (1987) and Gould et al. (1988) 
using radio-labeled microspheres and CT perfusion. Canine cerebral blood flow 
experiments were performed by Gobbel et al. (1993). Hattori et al. (1994) measured 
blood flow for superficial tumors. Cenic et al. (1999, 2000) developed a method for 
cerebral blood flow measurement and validated it against results obtained using 
microspheres. A kinetic based model was developed by Materne et al. (2000) for hepatic 
perfusion calculation and was validated using radiolabelled microspheres. Cuenod et al. 
(2001, 2002) used deconvolution method to calculate hepatic perfusion in rats. 
Wintermark et al. (2001) estimated cerebral blood flow by CT scans, using methods 
based on central volume principle (Meier and Zierler (1954)) and validated it against 
stable Xenon CT. 
Peters at al. (1987) introduced a technique of measuring blood flow for an organ 
which was later extended by Miles (1991) to develop maximum slope method. Miles et 
al. (1994, 1995) applied this method for renal and pancreatic blood flow measurements. 
Miles et al. (1993) modified this technique to estimate blood flow in liver. Blomley et al. 
(1995) proposed a modification in maximum slope method for hepatic blood perfusion 
estimation. Maximum slope method was used by Bader et al. (1998) to assess the effect 
of liver transplantation on hepatic perfusion and by Koenig et al. (1998) for early 
detection of cerebral ischemic stroke. 
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The indicator-dilution technique has evolved into various methods which can be 
broadly classified as model-free and model based approaches. Maximum slope model is 
the widely used example of model-free approach. Tracer kinetic models, which come 
under deconvolution methods, are examples of model based approaches. These are 
described in the following sections.  
      In 1983 Axel developed a technique based on deconvolution to estimate blood 
flow related parameters (Axel 1983). In this technique the response to a quantum of 
injected dye contrast agent in the given tissue, response function, is defined with a set of 
unknown parameters. With the help of the characteristic of the contrast agent at the time 
of injection and the assumed response function, the concentration of the contrast agent in 
the tissue as a function of time is calculated and compared with actual experimental 
values. The unknown parameters in response function are selected on trial and error 
basis, until a close enough match is obtained. The hence obtained parameters are then 
used to obtain blood flow related parameters. 
      The method developed by Axel, deconvolution, is mathematically involved and 
require the users to have knowledge about the tissue structure to be able to make 
assumptions about the response function. The maximum slope method is relatively 
inexpensive computationally. It was developed by Miles in 1991, based on the work done 
by Peters et al.1987. Miles et al. were the first to apply the maximum slope method to the 
liver and validate it using dynamic colloid scintigraphy (Miles et al. 1993). This method 
assumes that contrast material is accumulating in the body tissue and there is no venous 
outflow in this period. It calculates the blood perfusion values using the maximum 
concentration values in arterial flow and maximum slope in the concentration of contrast 
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material in the tissue. This method was developed only for single blood supply organs, 
which was further extended to dual supply organ, liver, by Miles et. al. in 1993. Blomley 
et al. suggested modifications to the maximum slope method for liver in 1995.  
             Some of the other methods which had been employed by researchers are 
moments method, compartmental methods and Mullani-Gould formulation. Table 5.2 
shows studies which have validated some of these methods primarily using microspheres 
and stable xenon washout. 
Comparative study 
Materne et al. proposed a version of tracer kinetic method for the liver perfusion, 
which was also compared using microspheres (Materne et al. 2000). The de-convolution 
method was first applied to liver by Cuenod et al. (2001). Maximum slope and tracer 
kinetic model are both based on dual input single compartment model, but are different. 
There have been studies comparing these methods by Kanda et al. in 2012.  
Tracer kinetic models 
It can be said that deconvolution method eventually evolved into tracer kinetic 
models. In these models the response function is defined with help of physiological 
parameters such as blood flow, blood volume, tissue permeability and amount of contrast 
agent extracted from the blood into the tissue (extraction fraction). The type and number 
of these unknown parameters varies within models, depending on the complexity of the 
model. The approach is to start with simplest model and check if this model is able to 
simulate the response as shown by experimental data (Sourbron and Buckley 2012). If the 
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match is satisfactory the model and the respective parameter values are accepted, 
otherwise a higher model with greater number of unknowns is tested.  
Table 5.2 Validation studies for moments method, mullani-gould method, maximum 
slope method, deconvolution method and compartmental method. 
Method Validation  






perfusion in dogs 
Gobbel  et al. 1991 Stroke 
Comparison: Xenon 
washout studies in 
humans 
Gobbel et al. 1993 Am J Neuroradiol 
   
Mullani-Gould 
Formulation 
Microspheres in canine 
myocardial studies 
Wolfkliel et al. 1987 Circulation 
Rumberger et al.1987 J Am Coll Cardiol 
Gould  et al.1988 Invest Radiol 





Hepatic perfusion Miles et al. 1993 Radiol 
 Miles et al. 1994 Invest Radiol 
 Miles et al. 1995 Br J Radiol 
 Koenig et al. 1998 Radiol 




Blomley et al. 1995 J Comput Assist 
Tomgr 






Stable Xenon CT, 
Human cerebral 
Cenic et al. 2000 Am J Neuroradiol 












Canine myocardial flow 









Some of the widely used tracer kinetic models are distributed parameter model (DP), 
2-compartment exchange model (2CXM), tissue-homogenity model (TH)( Sawada et al. 
1989 ), adiabatic approximation to TH model (AATH) (Cenic et al. 2000 and Purdie et 
al. 2001), tissue uptake models (TU), compartmental uptake model (C-TU) ( Pradel et al. 
2003) and plug flow uptake model (P-TU) (St Lawrence et al 2000). An important factor 
to consider while choosing the model is the physiology of the tissue/organ. Certain 
models are suited for certain types of physiologies for example DP is widely used for 
liver (Petralia et al. 2011, Guyennon et al. 2010, Goresky et al. 1973), 2CXM for breast 
tumors (Cheong et al. 2004 and Brix et al. 2004). 
Figures 5.1 and 5.2 illustrates the application of DP and AATH tracer kinetic models, 
respectively. Experiments were performed on white New Zealand rabbits were performed 
by Eleni Liapi. Data of the tissue concentration from artery, portal vein, spleen and 
healthy liver was collected from these experiments. DP and AATH model was applied to 
these data sets and the final set of parameters which gave the least errors and hence were 
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Figure 5.1: Set of parameters, plasma flow Fp, permeability PS, plasma volume vp, 
extracellular space volume ve, for hepatic artery and portal vein in distributed 
parameter model for subject 10. These set of parameters give the liver 
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Error = 1.56 
H.U. 
Figure 5.2: Set of parameters, plasma flow Fp, permeability PS, plasma volume vp, 
extracellular space volume ve, for hepatic artery and portal vein in adiabatic 
approximation model for subject 10. These set of parameters give the liver 




5.2 Maximum Slope Model Assumption Discrepancy and 




For diagnostic radiologic imaging purposes, quantification of the blood flow within the 
healthy and tumorous liver is crucial for differentiation of the tumorous tissue from the 
healthy tissue, as well as evaluation of tumor response to therapy (Kim et.al. 2014). The 
liver is an organ with unique flow dynamics, related to its dual vascular supply from the 
portal vein and the hepatic artery (Bradley et al. 1945, O’ Connor et al. 1988, Tygstrup et 
al.1962, Schenk et al. 1962) (figure 5.3). The hepatic artery supplies arterial blood to the 
liver, and accounts for approximately 25% of its blood flow, while the portal vein carries 
to the liver, venous blood drained from the spleen, gastrointestinal tract and its associated 
organs, supplying approximately 75% of its blood flow (Schenk et al. 1962). In contrast 
to liver, hypervascular primary and metastatic liver tumors are known to derive their 
vascular supply primarily from the hepatic artery, a well-known phenomenon and the 
basis of all intra-arterial therapies for these tumors (Liapi and Geschwind 2007, Cady and 
Oberfield 1974, Swinton et al. 1970). 
Hepatic artery supplies blood to the liver from the cardio-pulmonary circulation. 
Liver also gets blood supply from the portal vein, which is in turn fed by mesenteric and 
splenic vein coming from gut and spleen respectively (Fleming et al. 1983). Therefore 
the blood arriving to the liver from the main circulation comes through hepatic artery first 
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and then through the portal vein en route spleen and gut. This time lag in the blood 
coming through the portal vein is exploited in the maximum slope method, to 
differentiate between the arterial and portal blood flow in the liver tissue. 
      CT perfusion is used by interventional radiologist to analyze the blood flow 
within the liver for diagnosing cancer (Kim et.al. 2014). The ratio of the blood supplies 
coming from hepatic artery and portal vein can be obtained from CT perfusion and 
therefore it can be used to differentiate between malignant and normal tissue. In CT 
perfusion a contrast agent, which is opaque to the X-rays, is injected intravenously and a 
series of CT scans are performed to trace the contrast agent within the body tissue. The 
contrast agent reaches the tissue through the feeding artery and is eventually drained out 
through the venous outflow. CT scan images give the variation of contrast agent 
concentration with time. As mentioned earlier, analysis of the CT scan images is required 
in order to obtain blood perfusion values and the maximum slope method has been used 
here for the analysis.  
The maximum slope method assumes that the contrast material coming from the 
feeding artery accumulates inside the tissue, without any venous outflow. Therefore the 
slope of the tissue density curve (TDC), contrast agent concentration with time, gives the 
rate of intake of contrast material into the tissue. The TDC of the feeding artery gives the 
contrast concentration in the incoming blood flow to the tissue. By applying conservation 
of mass and equating the inflow of the contrast material to the rate of accumulation of 
contrast material in the tissue we get 
         
     
  




Figure 5.3. Illustration demonstrating blood circulation to the liver. Liver receives its 
blood supply from hepatic artery and portal vein. Blood arriving to the liver from the 
main circulation, first comes through the hepatic artery and after a time lag comes from 
the portal vein via the spleen and gut. 
where        is the concentration of contrast material in the blood supply feeding the 
tissue at time t, F is the flow rate of the blood supply,      is the concentration of the 
contrast material of the tissue at time t and V is the volume of the tissue. To calculate the 
blood flow rate per unit volume of the tissue, the maximum slope of the liver TDC is 
divided by the maximum concentration (enhancement) in the arterial TDC. For this it has 
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to be ensured that only that portion of the TDC is analyzed where the no-venous outflow 





Figure 5.4 Typical tissue density curves (TDCs) for artery, portal vein, spleen and 
liver. The concentration of the contrast medium, enahancement, is given in terms of 
Hounsfield Units (H.U.). From the time of peak enhancement of the arterial, splenic 
and portal vein curves the sequence of the appearance of contrast material can be 
ascertained. These are representation of the TDCs and not actual data points. 
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Figure 5.5. TDCs for liver and spleen, illustrating the arterial and portal phase, separated 
by the time of peak splenic enhancement, and the corresponding maximum slopes. Only 
that portion of the TDC is considered in maximum slope method which is after the start 
phase (SP) and the end phase (EP), defined by maximum enhancement values. These are 
representation of the TDCs and not actual data points. 
 As the liver receives its blood supply from two sources, the hepatic artery and 
hepatic portal vein, the maximum slope method needs to be modified to account for the 
dual-input. The contrast material coming from the main circulation comes directly to the 
liver through the hepatic artery, but it has to go through the spleen/gut in order to come 
through the portal vein (Fig 5.3). Therefore maximum slope method assumes that prior to 
the time of the splenic peak there is no contrast from other organs or tissues feeding the 
portal vein, thus up until this time, the liver is considered to be supplied with only arterial 
contrast. The time of maximal enhancement of spleen indicates the start of the portal 
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phase and the time of maximum tissue enhancement indicated the end of the portal phase. 
The bolus injection should be kept fast and short to avoid mixing of the two phases.  
Figure 5.4 illustrates a typical TDC for liver tissue along with artery, portal vein 
and spleen. The TDC for liver is divided into two parts (Fig 5.5), first when the arterial 
supply dominates and the second when the portal blood supply dominates. The two parts 
are separated by the time of maximum splenic enhancement.        
For hypervascular tumors, the time of maximal liver tissue enhancement may 
occur prior to or after the splenic maximal arterial enhancement. In the first case, we may 
then observe that the downward slope of the TDC of a tumor may occur before the spleen 
reaches its maximal enhancement, affecting therefore portal perfusion measurements. 
This anomaly was observed for some of the cases of hypervascular tumor, which lead to 
unreliable estimates of portal perfusion, while using maximum slope method. Other 
methods, such as tracer kinetic models, use the entire curve for the perfusion calculation 
and therefore do not have these problems. The aim of the present work was to evaluate 
the dual-input maximum slope method in calculating the hepatic arterial and portal 
perfusion of tumor in the VX2 rabbit liver model. We studied the TDC for 11 subjects 
(rabbits) and applied the dual-input maximum slope method for calculating the perfusion 
values. We specifically sought to examine whether the dual-input maximum slope 







Adult New Zealand White rabbits were used in this study.  All (n=11) weighed 
3.5–4.2 kgs prior to imaging.  Rabbits were housed in an Association for Assessment and 
Accreditation of Laboratory Animal Care (AAALAC)-accredited facility in compliance 
with the Guide for the Care and Use of Laboratory Animals (National Research Council 
1996) and procedures were approved by the Johns Hopkins Institutional Animal Care and 
Use Committee (IACUC). Male and female white New Zealand rabbits were selected for 
their relevance to intra-arterial procedures and liver tumor imaging as part of our ongoing 
studies on liver cancer therapy. At designated time points, individual animals were 
randomly selected for inclusion in study cohorts at which point they underwent 
implantation of rabbit VX2 tumor in the liver for subsequent CT perfusion imaging. 
These experiments were performed by E. Liapi .  
 
Animal Model And Tumor Implantation 
1
 
Each animal received tumor implantation in the left lobe of the liver as detailed in  
(Buijs et al. 2011, Lee et al. 2008). The tumors were allowed to grow in the rabbit livers 
for 13–15 days, after which time they were subsequently imaged (Yamamoto et al. 2006, 




                                                             
1
 The experiments were performed by E. Liapi and S. Mirpour 
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Wide-Array CT Perfusion Protocol 
2
 
For CT perfusion imaging, each rabbit was first sedated with intramuscular 
injection of ketamine and xylazine and subsequently scanned in a wide-array 320- 
clinical CT scanner (Aquillon ONE, Toshiba, Japan). The CT perfusion protocol included 
at least one non-contrast enhanced volume acquisition, followed by a series of contrast-
enhanced CT acquisitions. Iso-osmolar contrast iodixanol (1.5 ml/kg, 320 mg I/ml-
Visipaque, GE Healthcare Inc., Princeton, NJ) was injected intravenously at 1ml/sec via a 
21G butterfly needle inserted in a marginal ear vein, followed by a saline flush of 7 ml at 
the same rate. The CT perfusion scanning parameters were: FOV=22cm, KV=120, 
mA=80, slice thickness=0.5mm, scan delay=6 sec. Total intermittent scanning time for 
each rabbit scan was 77 seconds. Wide-array CT scans were obtained every 2 sec for the 
first 25 seconds, and every 3 seconds thereafter and for an additional 42 seconds. Each 
scan takes 0.5 sec (one volume acquisition equals a single gantry rotation at a speed of 
0.5 s per 360°rotation). A total of 27 acquisitions with 5,400 images were obtained during 
each CT perfusion study, which were subsequently transferred to a dedicated workstation 
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Image reconstruction and analysis 
Following CT acquisition, images were reconstructed with adaptive iterative dose 
reduction 3D (AIDR 3D; Toshiba Medical Systems, Japan), which is the manufacturer’s 
commercial hybrid IR algorithm, combining reconstruction in the raw data and image 
space domains. The reconstruction filter (FC03), and the reconstructed section thickness 
(5 mm) were fixed for all studies. 
Data was then exported to a dedicated workstation for image registration, using 
the manufacturer’s commercial software program (Body Registration; Toshiba Medical 
System, Tochigi, Japan) that automatically corrects the spatially non-consistent position 
of each organ among the 27-image series of each study. The program adjusted the 
position of each organ three-dimensionally, i.e., proportionally along any axis and 
rotationally.  
Maximum Slope Theory and Models 
The maximum slope (MS) method has been used to calculate the arterial and 
portal perfusion. MS method assumes no-venous outflow in the tissue, therefore only that 
portion of the TDC is considered which is before the start of venous outflow (Fig. 5.5). In 
Aquilion ONE (Toshiba) the point of maximum enhancement is chosen as the point of 
the start of the venous outflow and defined as End Phase (EP). By definition, after EP the 
enhancement starts to decreases, which is only possible if the contrast material is leaving 
the tissue, signaling venous outflow. Further, a start phase (SP) is defined as the point 
where contrast material starts entering the tissue, signified by the start of contrast 
enhancement. A short and fast contrast bolus is administered to make sure the no-venous 
outflow assumption is valid. 
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In a single supply organ the maximum slope of the TDC between the SP and EP is 
calculated and divided by the peak enhancement of the supplying artery, to obtain the 
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where F is the blood flow rate in the tissue, V is the tissue volume, SP is the start phase, 
EP is the end phase, SM is the time at which spleen attains maximum enhancement,      
and      are the concentration of contrast medium in the tissue and artery at a time 
instant t .  
With liver being a dual blood supply organ, fed by hepatic artery and portal vein, 
a different approach is used. The TDC can be, therefore, divided into two phases, the 
arterial phase, which is dominated by the arterial flow and the portal phase, which is 
dominated by the portal venous flow (Figure 5.5). These regions are separated at the 
point of maximum splenic enhancement (SM). The arterial and portal blood perfusion is 
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is the portal blood 
flow rate per unit tissue volume, SM is the time at which spleen attains maximum 
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enhancement, and      is the concentration of contrast medium in the portal vein at a 
time instant t .  
By placing circular regions of interest (ROIs) over the aorta, the main portal vein, 
the right and left lobes of the liver, as well as over each entire tumor at the level of each 
longest axial diameter, TDC were derived.  The size of each ROI was at least 1.0 cm
2
 or 
larger, except for that in the portal vein and the aorta, which were set to cover their 
shortest axis at the level of the hepatic hilum (and with a diameter of 1.0 mm
2
). 
Perfusion was calculated by using: a) the dedicated commercial software, on a 
pixel by pixel basis, that uses the dual-input maximum slope model (Body Perfusion; 
Toshiba Medical System, Tochigi, Japan), and b) MATLAB Code (Mathworks, Natick 
MA).  Flow measurements were expressed in mL per 100 mL per min. Arterial flow 
(AF), portal flow (PF) and perfusion index (PI) were calculated for tumor, left and right 
hepatic parenchyma.  
A MATLAB (Mathworks, Natick MA) code was developed to implement the 
maximum slope method and calculate the perfusion values. After background subtraction, 
as described earlier, curve fitting was done for all the TDCs using ‘smoothingspline’ 
function in MATLAB. The fitted TDCs were discretized using a time step of 0.1 s for 
calculating maximum value or slope. The time corresponding to the maximum 
enhancement point for left/right liver and tumor ROI was taken as the EP point. For 
choosing the SP, we choose that point where the enhancement reached 10 % of the 
maximum enhancement in the corresponding TDC. The hepatic arterial perfusion (HPA) 
and hepatic portal perfusion (HPP) values were calculated using equation (5.3) and (5.4) 
respectively. The perfusion value hence obtained has ‘1/s’ units, which is then changed to 
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‘ml/(min.100ml)’ by multiplying the perfusion value with 100*60 [ml. s/(min.100ml)]. 
The perfusion index was calculated using equation (5.5). The data was recorded and 
analyzed for 11 subjects. 
    
   
         
                                                (5.5)   
Imaging analysis algorithm: ROIs 
Images were processed in Toshiba CT scanner. The regions of interest (ROIs) 
were selected for the artery, portal vein, spleen, healthy liver (left/right) and tumor as 
shown in figure 5.6. The Toshiba software generated TDCs corresponding to these ROIs. 
CT scan comprised of 25 scans and therefore each of the six curves, corresponding to 
different ROIs, had 25 data which were recorded and used for the calculation of perfusion 
values. In order to remove the background noise the average of the first two points is 
subtracted from all the points. 
Arterial and portal flow for tumor, left and right liver were calculated with the use of 
the commercial software (Body Perfusion, Toshiba) (Figure 5.7), as well as by extracting 
HU values from the TDC curves to MATLAB software (MathWorks, Natick, 
Massachusetts)  and subsequently deriving perfusion values from the equation.  
5.2.2 RESULTS 
The maximum arterial and portal enhancement for 11 subjects is shown in Table 
5.3. It also shows the SP and time to peak points of artery, portal vein and spleen. The SP 
of artery denotes the entering of contrast material in the artery and therefore starts the 




Figure 5.6. Regions of interest: (a) artery, (b) portal vein, (c) spleen, (d) left liver, (e) 
right liver and (f) tumor 
comparison between subjects difficult. In order to normalize and therefore facilitate intra 
subject comparison all the time points have been subtracted by the SP time of artery. The 
normalized values are given in the last two columns of Table 5.3. Figure 5.8 shows the 
time of maximum enhancement for artery, portal vein and spleen for different subjects. 
The average values of the time of maximum enhancement, along with standard deviation, 




Figure 5.7. Color map for patient 33, with region of interest around a tumor, showing (a) 
Hepatic Arterial Perfusion (HAP), (b) Hepatic Portal Perfusion (HPP), (c) Hepatic 






Table 5.3. The maximum enhancement of artery and portal vein. Start phase and time at 
maximum enhancement for artery, portal vein and spleen. 
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Figure 5.8. Time of maximum enhancement for artery, spleen and portal vein in 11 
subjects. Figure insert shows the average time of maximum enhancement for artery, 
spleen and portal vein in 11 subjects. X-error bar denotes the standard deviation in 
average values. Artery attains maximum enhancement the earliest followed by spleen and 







Table 5.4. Time of start phase (SP), arterial maximum slope, portal maximum slope and 
end phase (EP) for left/right liver and tumor. 
       
Normalized 
Patient ROI Start Arterial Portal End 
 
Start Arterial Portal End 
No. 
 
phase Slope slope Phase 
 
phase slope Slope phase 
  [s] [s] [s] [s]  [s] [s] [s] [s] 
           
10 Left Liver 12.6 20.3 30 40 7.8 15.5 25.2 35.2 12.6 
 
Right Liver 16.9 17.6 25.6 39.1 12.1 12.8 20.8 34.3 16.9 
 
Tumor 9.4 13.3 20.3 23.7 4.6 8.5 15.5 18.9 9.4 
11 Left Liver 22 30.6 34.7 46.8 13.4 22 26.1 38.2 22 
 
Right Liver 25.7 29.9 30.6 45 17.1 21.3 22 36.4 25.7 
 
Tumor 13.4 19.7 na 29.5 4.8 11.1 na 20.9 13.4 
12 Left Liver 14.8 24.9 31.9 39.6 9.6 19.7 26.7 34.4 14.8 
 
Right Liver 13.6 24.9 30.1 46 8.4 19.7 24.9 40.8 13.6 
 
Tumor 9.9 15.9 24.9 30.9 4.7 10.7 19.7 25.7 9.9 
14 Left Liver 15.5 24.6 33 41.8 10.2 19.3 27.7 36.5 15.5 
 
Right Liver 15.2 24.6 29.8 43.8 9.9 19.3 24.5 38.5 15.2 
 
Tumor 9.7 12.2 24.6 25.3 4.4 6.9 19.3 20 9.7 
15 Left Liver 17.8 21.8 30 39.4 12.9 16.9 25.1 34.5 17.8 
 
Right Liver 18.1 21.8 33 46.6 13.2 16.9 28.1 41.7 18.1 
 
Tumor 8.4 15.9 21.8 29.1 3.5 11 16.9 24.2 8.4 
20 Left Liver 11.5 17.1 22 32.3 9.4 15 19.9 30.2 11.5 
 
Right Liver 13.2 17.1 23.8 34.3 11.1 15 21.7 32.2 13.2 
 
Tumor 5.2 12.4 17.1 17.6 3.1 10.3 15 15.5 5.2 
23 Left Liver 17.5 24.2 26.3 40.6 14.5 21.2 23.3 37.6 17.5 
 
Right Liver 17.9 22.5 31.9 46.7 14.9 19.5 28.9 43.7 17.9 
 
Tumor 7.8 12.3 24.2 26.2 4.8 9.3 21.2 23.2 7.8 
24 Left Liver 19.4 26.2 28.3 44.5 13.8 20.6 22.7 38.9 19.4 
 
Right Liver 20.2 25.4 34.1 42.9 14.6 19.8 28.5 37.3 20.2 
 
Tumor 11.1 13.2 26.2 30 5.5 7.6 20.6 24.4 11.1 
33 Left Liver 26.3 30.4 35 48.1 15 19.1 23.7 36.8 26.3 
 
Right Liver 30.1 30.4 34.9 50.1 18.8 19.1 23.6 38.8 30.1 
 
Tumor 17.8 22.9 n.a. 30.3 6.5 11.6 na 19 17.8 
40 Left Liver 14.4 17.5 26.4 39.8 10.4 13.5 22.4 35.8 14.4 
 
Right Liver 12.8 17.7 36.1 41.1 8.8 13.7 32.1 37.1 12.8 
 
Tumor 7.3 14.5 17.7 21.5 3.3 10.5 13.7 17.5 7.3 
41 Left Liver 13.5 19.4 28.9 37 9.9 15.8 25.3 33.4 13.5 
 
Right Liver 13.8 20.6 24.1 37.9 10.2 17 20.5 34.3 13.8 
 




Table 5.5. Perfusion value comparison: CT scanner vs. calculated values 










HAP HPP HPI 
 
HAP HPP HPI 
No. 
   
(ml/(min. 100ml)) (%) 
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33.6 92.2 26.7 
 





34.9 162.7 17.6 
 




57.2 68.6 45.5 
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80.5 159.5 33.5 
 




76.4 0.0 100.0 
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17.9 113.1 13.7 
 




49.0 0.0 100.0 
 




The key points in the TDCs curves are the start/end phase and the point where the 
maximum arterial/portal slope is obtained. These points of left/right liver and tumor ROI 
for different time subjects are given in Table 5.4. Table 5.5 gives the perfusion values for 
left/right liver and tumor ROIs calculated using equations 5.3-5. The corresponding 
values obtained from the CT perfusion software Aquilon is also give in the table.  
 
Figure 5.9. Time of start phase (SP), arterial maximum slope, portal maximum slope and 
end phase (EP) for healthy liver in 11 patients, along with the respective splenic 
maximum time. The portal phase has a larger duration than the arterial phase. The time of 





Figure 5.10. Time of start phase (SP), arterial maximum slope, portal maximum slope 
and end phase (EP) for tumor in 11 patients, along with the respective splenic maximum 
time. Note that for patients 11, 33 and 41 end phase points were before splenic maximum 
and therefore portal slope could not be calculated and has been marked fictitiously at 
corresponding end phase values by red circle. The duration of portal phase is much 





Figure 5.11.  Average values of key time points for liver and tumor, along with standard 
deviation. Average time of maximum splenic enhancement is also shown. There is time 
difference between splenic maximum and EP/SP for healthy liver. For tumor, the EP 
region is overlapping the splenic maximum region, this might make it unfeasible to 





Figure 5.12. Arterial phase duration for healthy liver and tumor. Healthy liver have lower 
arterial phase duration than tumor. This result is expected as tumor has an early SP and is 
primarily fed by artery, in contrast with healthy liver which receives majority of its blood 





Figure 5.13. Portal phase duration for liver and tumor. Portal phase duration  for tumor is 
very small and is non-existent for 3 (11, 14 and 41) out of the 11 subjects investigated. It 
can also be seen that the duration for liver is much larger than that of tumor, this is due to 
the fact that healthy liver has a late EP and receives majority of the blood supply from 
portal vein, whereas tumor gets the major portion of the blood supply from the tumor.  
 The TDC curves relevant to the MS method lie between the start phase and the 
end phase, signifying the start of the venous outflow. The start phase and the end phase of 
healthy liver in all 11 subjects are shown in Figure 5.9. As mentioned, earlier this main 
portion of the TDC curve is divided into arterial and portal phase by the time it takes for 
the spleen to attain maximum enhancement. Subsequently, the maximum slopes in the 
arterial and portal phases are calculated. The time corresponding to maximum arterial and 
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portal slope and splenic maximum enhancement is also illustrated in the same figure. 
Figure 5.10 illustrates these points corresponding to the tumorous region in the subjects. 
The average of these key time points for healthy and tumorous liver is illustrated in 
Figure 5.11, x-error bars represents the standard deviation. It can be seen that tumor starts 
earlier and ends earlier than healthy liver. The splenic maximum region is closer to the 
start phase for the healthy liver and to the end phase for tumor. The TDC curve from SP 
to EP for healthy liver is around 30 s and for tumor is around 20 s. 
The arterial phase duration is greater for tumor as compared to a healthy liver as 
shown in Figure 5.12, on the other hand tumor has greater portal phase duration (Fig 
5.13). For healthy liver the duration of arterial phase is greater than portal phase, whereas 
for tumorous region this is reversed. These results are expected as healthy liver gets 
majority of its blood supply from portal vein and tumor’s blood supply is dominated by 
hepatic artery.   
Figure 5.13 also illustrates the problem in using the maximum slope method to 
calculate the portal perfusion for tumor. Out of eleven subjects, three (11, 33 and 41) 
have a negative portal phase duration, this is due to the fact that for these cases the 
splenic maximum enhancement occurs after the end phase of the liver. By definition, 
portal slope can only be calculated from that portion of TDC which lies after the splenic 
maximum and before venous outflow (EP). Therefore, this demonstrates that it is not 





Figure 5.14. TDC for spleen, liver and tumor in subject 23. Time of maximum 
enhancement  for spleen and end phase for liver and tumor has been marked by vertical 




Figure 5.15. Rate of change of enhancement (
     
  
), slope of the TDCs (    ), for liver 
and tumor in subject 23. The slope of a curve becomes zero as it reaches to its maximum. 
Therefore, the maximum for TDC can be clearly seen in this figure as the point where the 




Figure 5.16. TDC for spleen, liver and tumor in subject 11. Tumor does not seem to have 
a portal phase as the spleen attains its maximum after the end phase of tumor. Spleen 





Figure 5.17. Rate of change of enhancement (
     
  
), slope of TDCs (    ), for liver and 
tumor in subject 11. Under the no-venous outflow assumption rate of change of 
enhancement translates into the rate of intake of contrast medium inside the tissue. After 
the EP point of tumor at 29.6 s the rate drops below zero, indicating outflow of contrast 
medium from the tissue. As the splenic maximum occurs after the EP of tumor, there is 





Figure 5.18. TDCs for spleen, liver and tumor in subject 33. The maximum enhancement 
of tumor (EP = 44 s) occurs after a dip in the TDC curve. A decrease in enhancement 
value signifies venous outflow and selecting EP after that violates the underlying 
assumption of maximum slope method. Therefore any maximum occurring after a dip in 
the TDC should be rejected and only that maximum point should be selected which 




Figure 5.19. Rate of change of enhancement (
     
  
), slope of TDCs (    ), for liver and 
tumor in subject 33. According to Figure 5.18 the tumor TDC is reaching maximum at 44 
s. The rate of change of enhancement for tumor can be seen crossing the zero line at 44 s, 
but it also crosses the line before that at 30.3 s. The entry of this curve below the zero line 
is indicative of the start of venous outflow and hence it violates the underlying 






       Figure 5.14 illustrates the TDCs for healthy liver, tumor and spleen in subject 23. 
The tumor curve attains its maximum at 26 s and as discussed in the materials and 
method section this is taken as the end phase (EP) for tumor. Similarly left and right liver 
have EP points at 40.5 s and 46.5 s. For this subject all the EPs are after 24.1 s, splenic 
maximum, and therefore it is possible to calculate the portal perfusion for this case. The 
slopes of the left/right liver and tumor TDCs are plotted in figure 5.15. The slope of a 
curve becomes zero at its maximum and therefore the slope curve crosses the zero line at 
the corresponding EP points.  
Table 5.3 and 5.4 shows the time of maximum enhancement for spleen and the 
end phase time for tumor. For the dual supply the maximum slope method to be 
applicable, the time of maximum splenic enhancement should be prior to the end phase of 
the tumor. This condition is satisfied for all but three subjects, 11, 33 and 41. There is 
another type of discrepancy which arises with subject 33. Although the end phase of the 
tumor in subject 33 is after the splenic maximum, the method of selection of end phase 
leads to violation of no-venous outflow assumption. The case of subject 11 and 33 has 
been analyzed in detail later in this section. 
The TDCs for healthy liver and tumor in subject 11 are plotted separately in 
figure 5.16. The end phase of left and right liver occurs at 46.7 s and 45 s which is more 
than 13 s after the peak time of the spleen 30.5 s. The time between the splenic maximum 
and end phase is when the portal flow dominates and the maximum slope of the TDC 
curve is recorded here. In the case of tumor the end phase is at 29.6 s which is before the 
peak time of spleen. So for tumor it seems that by the time the portal flow starts to 
dominate the tumor TDC has gone beyond the maximum, signaling the start of the 
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venous outflow and hence the maximum slope model cannot be applied to find the 
hepatic portal flow for the tumor. Similar discrepancy is observed for subject #41.            
             Another type of discrepancy was observed in subject 33. The TDCs for spleen, 
liver and tumor are shown in figures 5.18. The slope for the left/right liver and tumor is 
illustrated in figure 5.19 and the key time points of the TDCs are shown in Table 5.3 and 
5.4. 
         In this case although the end phase for the tumor occurs at 44 s, 13.5 s after the 
splenic maximum (30.5 s), the no-venous outflow assumption has been violated here. 
Figure 5.18 shows that soon after the splenic maximum, and therefore during the portal 
phase, a dip is observed in the enhancement values. The tumor TDC attains local 
maximum around 31 s and after that keeps on decreasing till 34 s. This becomes clearer 
in the Figure 5.19, where the slope of the curve goes below the zero line around 32 s. 
This shows that the contrast material has started to leave the tissue, making the no-venous 
outflow assumption invalid. The TDC for liver attains its global maximum at 44 s and the 
maximum portal slope is calculated at 39.25 s. The slope for portal slope was calculated 
where the no-venous outflow assumption was not valid. 
5.2.3  DISCUSSION 
As the healthy liver primarily gets its blood supply from the portal vein it has 
higher portal phase duration than tumor as seen in figure 5.12. On the other hand tumor is 
predominantly fed by hepatic artery and therefore it can be seen in figure 5.13 that tumors 
have higher arterial phase duration as compared to healthy liver. 
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 It was observed that in some of the cases maximum splenic enhancement occurred 
after the end phase of tumor. This is something which is not expected according to the 
maximum slope method. There should ideally be a portion of tissue concentration curve 
after splenic maximum and before tumor maximum, which can be used to calculate 
maximum slope and hence blood perfusion rate. Under these circumstances the only 
possible estimate is that the tissue is receiving all its blood supply from hepatic artery, 
which does not seem to be plausible. Another problem which was observed here is the 
presence of local maxima in the tumor TDC curves, which occurred very early in the 
curves. By assumption inherent in the maximum slope model only the first maxima can 
be used as an end point, this can lead to ambiguity in some cases. One of the reasons 
behind these discrepancies is also that this method will benefit from more rigorous 
validation.  There are also large variations present in blood perfusion values when 
evaluated using different methods. The solution to these discrepancies is to use other 
methods, tracer kinetic models, for evaluating blood perfusion values. 
5.2.4 CONCLUSION 
           Maximum slope method was investigated to examine two anomalies present in the 
calculation of perfusion values. In the MS method the location of splenic maximum 
enhancement is crucial as it divides the arterial and portal phase. In some of the cases 
discussed in present work the splenic enhancement was occurring after the end point of 
the liver, due to which maximum slope method was unable to give an accurate HPP. 
Secondly, local minima was observed in the liver concentration curves which makes it 
difficult to accurately define the end phase of liver, which is again crucial for the 
calculation of perfusion values. Considering these limitations it is advisable to use other 
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methods for perfusion calculation where data accuracy is critical, such as while analyzing 
the heat transfer within the tissue. For other application it might be only necessary to 
check if the perfusion values are above a set cut-off, in such cases further work needs to 
















OPTIMIZING TEMPORAL SAMPLINGS 
The complete authorship of this work should be read as Rajeev Hatwar, Prof. Eleni Liapi 
and Prof. Robert Ivkov. The experiments were performed by Prof. Eleni Liapi. 
Optimization of temporal protocol was performed by Rajeev Hatwar under the guidance 
of his advisor, Prof. Robert Ivkov. The work also benefited from comments of Prof. 
Charles Meneveau. 
 
6.1 INTRODUCTION  
X-ray computer tomography (CT) involves exposure to radiations which can have 
an adverse effect on the body. The risk of cancer death associated with an abdominal scan 
is 12.5/10,000, which is comparable to the risk from a year of smoking (12/10,000) (Gray 
1996). So there is a need to optimize the radiation dose, so as to get quality results 
without exposing subjects to more than necessary radiations.  
There are three approaches to reduce the radiation dose during scanning. It can be 
reduced by decreasing tube current and tube voltage (Othman et al. 2016). Radiation dose 
is more sensitive to the tube voltage as compared to tube current, as it is proportional to 
tube voltage by power greater than 2 and “linearly related” to tube current. In the case of 
tube current noise increases with decreasing current, so there is a trade-off between image 
quality and radiation dose. Lastly, radiation dose can be reduced by decreasing the 
number of scans, decreasing the temporal samples. 
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           Work has been done to optimize the number of samples needed to calculate 
various relevant parameters. To our knowledge all of them, have focused on analyzing 
equal time intervals (Ng et al. 2013, Kloska et al. 2010, Kamena et al. 2007, Goh et al. 
2008, Kambadakone et al. 2011, Wiesmann et al. 2008, Wintermark et al. 2004, Ng et al. 
2015, Bisdas et al. 2009) and they are retrospective studies. Table 6.1 gives the various 
methods which were used to calculate blood perfusion and the body tissue to which it 
was applied.  
Table 6.1 Protocol optimization studies undertaken along with the respective methods 
and body tissue 
 Method Body tissue 
Ng et al. 2013 Distributed Parameter model Lung 
Kloska et al. 2010 Maximum slope method Head 
Kamena et al. 2007 Deconvolution method Head 
Goh et al. 2008 Distributed parameter model Colon/rectum 
Kambadakone et al. 2011 Deconvolution method Abdomen/Pelvis 
Wiesmann et al. 2008 Deconvolution method Head 
Wintermark et al. 2004 Deconvolution method Head 
Ng et al. 2015 Distributed parameter model Liver 
Bisdas et al. 2009 Tracer kinetic model Head/neck 
 
Equal time intervals approach is justifiable for tracer kinetic models, like 
distributed parameter, which use the entire curve for the perfusion calculation. In case of 
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model-free approaches, like maximum slope method, the values are collected only at 
certain key points and not from the entire curve. Therefore some points on the curve are 
definitely more important than the other. Considering this, we have explored the 
possibility of using variable sample intervals in the present work. 
 Different methods have been employed to obtain an optimized protocol. The 
existing method of equal spaced time intervals is first analyzed. This is followed by a 
subject specific search for an optimized protocol for a fixed number of scans. All possible 
combinations of experimentally available temporal points are tried and tested against the 
full protocol by using a cost function, which comprises of different parameters related to 
perfusion. In order to obtain a common protocol, which can be applied to all the subjects, 
another set of calculations are performed in which all possible combinations are tried and 
the cost function comprises of all the subjects simultaneously. The results from these 
algorithms are tested against fixed interval case.  
6.2 MATERIALS AND METHODS 
Wide-array 320-slice clinical CT scanner, Aquilion ONE, from Toshiba Japan 
was used here. Twenty-eight adult male New Zealand white rabbits were used with VX2 
liver tumor. Iso-osmolar contrast iodixanola was injected intravenously through a 
marginal ear vein at 1ml/sec. Contrast agent was injected intravenously and 25 scans 
conducted of 0.5 seconds each. The experiments were conducted by E. Liapi and S. 
Mirpour. Wide-array CT scans were obtained every 2 sec for the first 25 seconds, and 
every 3 seconds thereafter and for an additional 42 seconds. 
  For the retrospective study 11 subjects were considered and the analysis was 
done using them to find the optimized temporal protocol. This was followed by a 
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prospective study where the optimized protocol was applied on a new set of 17 subjects 
and then the accuracy of the optimized protocol was tested. 
  Several different protocols were tested during optimization and are described 
later in this section. The cost function used for the optimization process calculates the 
percentage error in HAP, HPP and HPI for the healthy liver (equations 6.1-3) and takes 
average of all them (equation 6.4).  
          |
                             
                
|                                                            
          |
                             
                
|                                                            
          |
                             
                
|                                                              
                         
                
                                          ⁄  
The cost function used here had equal weightage for HPI, HAP and HPP. Since 
HPI includes HAP and HPP (Equation 5.5), this combination inherently gives more 
weightage to hepatic perfusion index, which is useful for interventional radiologist. 
 All the tissue density curves are standardized by fixing the starting point to the 
beginning of the appearance of contrast agent in the arterial curve. To calculate the 
starting point first the background noise is subtracted from the curves. For this the first 
two points are used to calculate average background noise which is subtracted from the 
respective curves. Then the starting of the arterial curve is decided using a cut-off of 100 
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H.U. The tissue density curve with all 25 experimental data points is used for generating 
a fitted curve. In the present work ‘smoothing spline’ function is used for curve fitting. 
These curves are shifted so that all of them begin at arterial start time.  
In the case of equally spaced time intervals, data points at an interval of 0.5 s are 
extracted from the fitted and standardized curve, starting at 0 s and ending at 40 s, and 
this is assumed to be the gold standard for calculating error. The end phase in the 
standardized curves were occurring within 40 s and therefore points after this were not 
included. For comparative analysis data points are extracted at an interval of 1 s, 2 s, 3 s, 
4 s, 5 s, 6 s, 8 s and 10 s. ‘Smoothing spline’ fitting is used for curve fitting with these 
points. These fitted curves are used for calculating the perfusion related parameters. 
For the case of variably spaced time interval, data at the following time points, 
which is based on existing protocol, are extracted from the fitted and standardized curves:  
0 s, 2 s, 4 s, 6 s, 8 s, 10 s, 12 s, 14 s, 16 s, 18 s, 20 s, 24 s, 28 s, 32 s, 36 s and 40 s. 
The data points hence obtained are used subsequently for all analysis related to variably 
spaced time intervals. The fitted curve based on these 16 points is used to calculate the 
gold standard values for all the relevant parameters. All possible combinations of 4 to 16 
time points are chosen out of these data points, followed by ‘smoothing spline’ curve 
fitting. The best possible combination for a given number of time points is selected which 
gives the lowest cost function. First this optimization is carried out individually for all the 
subjects, to get a protocol customized according to each subject. The protocol obtained 
through this process gives the smallest cost function for the corresponding subject. 
Subsequently, it is extended to obtain a protocol which gives the lowest average cost 
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function across all subjects, and is common to all the subjects. Once a common protocol 
is obtained using the retrospective analysis, it is applied to prospective data. 
In the retrospective study the temporal samples before 40 s are chosen. The 
maximum slope method does not use the points once the maximum of tissue has reached. 
In all the subjects studied this point was before 40 s. Different combinations of protocols 
are tested against a gold standard to check the variation in the cost function.  
6.3 RESULTS AND DISCUSSION 
Figure 6.1 shows the deviation of the hepatic arterial perfusion with increase in the 
time interval between different temporal samples. The x axis represents the actual values, 
obtained using the gold standard of 0.5 seconds interval. HAP for different time intervals 
is plotted on the y axis. A line corresponding to an exact match is plotted on each of the 
subplots. The further the points are from this line the poorer is the approximation. As the 
time interval is increasing the points are moving further away from the straight line. 
There is an over prediction as the sample interval increases. Similar trends are observed 
for other parameters: hepatic portal perfusion, hepatic perfusion index, maximum arterial 
contrast, maximum portal vein contrast, arterial maximum slope and the portal maximum 
slope.  
 Table 6.2 shows the percentage error for each subject for different lengths of time 
intervals ranging from 0.5 seconds (83 scans), gold standard, to 10 seconds (7 scans). 
Error has been calculated by averaging the errors (cost function) in HAP, HPP and HPI 
for healthy liver regions. The error gradually increased with the increase in the length of 
time intervals, though the increase in error varied for different patients. The error with 10 
seconds time interval varied from around 14 % to 46 % within different subjects. Figure 
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6.2 shows the pictorial representation of table 6.2. It can be seen that the errors decrease 
with increasing number of scans. The variability in the error among different subjects can 
be clearly seen in the figure. 
 
          
HPI gold standard 
HPI measured 
23 scans 16 scans 13 scans 
9 scans 8 scans 7 scans 
    = 2 s     = 3 s     = 4 s 
    = 6 s     = 8 s     = 10 s 
Figure 6.1: The effect of increasing time intervals, for equally spaced time interval, 
on the computation of HPI for different subjects has been shown here. Note that 
only the healthy liver tissue was considered here. The HPI for the gold standard 
case of 0.5 s time interval is given on the horizontal axis and other are plotted on 
the vertical axis. HPI estimation deteriorates with increasing time intervals and for 









10 8 6 5 4 3 2 1 0.5 
Number of 
          
samples 
 
5 6 7 9 11 14 21 41 81 
Total 
          
samples 
 
7 8 9 11 13 16 23 43 83 
           
Subject 
Tag 
          
           
10 
 
28.92 28.45 15.03 10.76 5.70 2.63 1.32 0.19 0 
11 
 
38.89 34.11 30.08 24.99 17.63 10.72 3.30 0.31 0 
12 
 
24.27 22.75 16.10 12.93 6.57 2.38 0.41 0.05 0 
14 
 
18.04 14.23 9.68 7.92 4.58 3.44 1.68 0.23 0 
15 
 
23.32 24.98 14.40 10.64 5.38 1.87 0.28 0.55 0 
20 
 
40.63 44.14 33.41 26.83 18.16 9.64 3.32 0.16 0 
23 
 
21.84 20.79 14.00 11.49 9.24 5.45 2.07 0.11 0 
24 
 
13.76 12.17 5.92 3.61 1.56 0.58 0.67 0.08 0 
33 
 
43.36 57.13 34.64 27.73 19.72 11.96 4.50 0.35 0 
40 
 
46.17 52.23 28.61 15.23 11.93 8.63 7.10 1.57 0 
41 
 
17.80 18.53 14.47 6.96 1.89 2.79 3.44 0.93 0 





28.82 29.95 19.67 14.46 9.31 5.46 2.55 0.41 0 
 
 
The results from the subject specific study, where different combinations of 
temporal protocols were tried for individual subjects, are presented in table 6.3 and 
illustrated in figure 6.3. Errors obtained from the abbreviated protocol for individual 
subjects have been plotted against the number of scans in figure 6.3. The total number of 
Figure 6.2: Variation of error in calculation of perfusion values for different subjects 
as a function of number of scans. Here equal duration of time intervals was used. 
Error decreases as the number of scans increases. The error calculated here is based 




scans was varied from 6 scans to 18 scans and the errors decreased as the number of 
scans increased. The errors for all the subjects and number of scans considered here were 
lower than 2.5 %. 
Table 6.3:  Error for different subjects with variable time intervals. Here the protocol was 
obtained separately for different subjects 
Free 
samples 
4 5 6 7 8 9 10 11 12 13 14 15 16 
Total 
samples 
6 7 8 9 10 11 12 13 14 15 16 17 18 
Subject 
             
              
1 1.10 0.18 0.55 0.13 0.11 0.05 0.04 0.06 0.08 0.06 0.03 0.02 0 
2 0.66 2.01 1.47 1.35 1.64 1.60 0.91 0.56 0.21 0.02 0.06 0.13 0 
3 1.52 0.80 0.36 0.08 0.20 0.07 0.06 0.06 0.06 0.03 0.02 0.04 0 
4 0.47 0.31 0.19 0.36 0.36 0.24 0.25 0.29 0.16 0.02 0.03 0.05 0 
5 0.41 0.13 0.17 0.09 0.05 0.03 0.04 0.03 0.09 0.08 0.05 0.04 0 
6 0.92 0.73 0.43 0.37 0.14 0.23 0.07 0.09 0.03 0.02 0.04 0.05 0 
7 0.84 0.32 0.24 0.06 0.05 0.16 0.16 0.11 0.07 0.04 0.09 0.05 0 
8 0.70 0.11 0.11 0.05 0.03 0.26 0.15 0.02 0.02 0.01 0.01 0.03 0 
9 1.12 0.44 0.31 0.28 0.47 0.61 0.15 0.14 0.06 0.03 0.07 0.12 0 
10 2.18 0.75 0.74 0.14 0.09 0.06 0.07 0.04 0.03 0.01 0.07 0.06 0 
11 0.14 0.06 0.06 0.13 0.05 0.02 0.03 0.21 0.09 0.02 0.04 0.01 0 
              




            
Figure 6.3: Variation of error in calculation of perfusion values for different subjects 
as a function of number of scans. Here variable duration of time intervals was used. 
For a given number of scans all possible combinations of available temporal scans 
were tried for each of the subjects separately, and therefore the protocol obtained are 
different for all the subjects. Error decreases as the number of scans increases. The 
error calculated here is based on the average error in HPA, HPP and HPI values for 
healthy region. Note that the errors obtained here are lower than the one obtained from 





 Figure 6.4 is a pictorial representation of the best 50 combinations of temporal 
samples for a given number of free samples in the case of Subject 1 (10). The samples 
were arranged in the increasing order of cost function. On the y-axis different 
combinations are shown, with best combination at the top. The horizontal axis, x-axis, 
represents the time since the start of the arterial phase. The constituents temporal samples 
of a particular combination are marked in blue color and the samples which are left 
behind are kept as yellow. Some of the temporal samples were more frequently present in 
the best 50 cases than others. The most frequent temporal samples occurred at 12 s, 24 s 




Free samples 4 Free samples 5 
Free samples 6 Free samples 7 
Free samples 8 Free samples 9 
Figure 6.4: Optimized best 50 cases of subject 10 for variable spaced intervals. All 
possible combinations of temporal samples were tried for a given number of temporal 
samples and the best 50 cases have been shown pictorially in these plots. Horizontal 
axis represents the temporal samples and the vertical axis shows the best 50 cases in 
with decreasing order of rank with the best 50 cases in with decreasing order of rank 
with the best case at the top.  
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 The tissue density curves of artery, portal vein, spleen and healthy liver for 
subject 1 (10) are shown in figure 6.5. Curves for artery, portal vein and spleen are 
plotted on the left y-axis. For clarity, liver curve is plotted on the right y-axis. Different 
temporal points along with their serial numbers are shown at the bottom of the figure. 
Further, time points corresponding to arterial and portal slope calculation and end points 
are marked by black circles. The significance of temporal samples at 12 s, 24 s and 28 s 
can be seen in this figure. It should be noted here that these time points are from the start 
of the arterial curve as described in the methods section. The maximum of the arterial 
curve occurs at around 12 s. The portal slope maximum and the maximum of the liver 
occurs around 24 s and 28 s. These instances are important in the calculation of perfusion 
values and hence are prominently occurring in the best cases. 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Figure 6.5: Tissue density curves of artery, portal vein, spleen and liver for subject # 
10.Arterial, portal vein and splenic curves are plotted on the left y-axis. A separate 
right y-axis is used for plotting liver curve. Different temporal time points can be seen 
in the figure.  
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The optimized protocol, which is common across all the subjects, is shown in 
figure 6.6 and table 6.4. It can be seen that in the optimized protocols 10 s, 12 s and 28 s 
are present in all the cases with different number of free samples. These are the times 
around which maximum in the artery and portal maximum slope is observed, and 
therefore these time points are so prominently occurring in the optimized protocol. As 
can be seen clearly in figure 6.6 the time points after 10 s are more important than the 
once occurring before it. In the optimized protocols only one of the time points before 10 
s are chosen till the number of free samples are less than or equal to 9. The selection of 
these time points, occurring before 10 s is scattered as compared to the occurrence of 





Figure 6.6: Optimized common temporal samples for a set number of free samples. 
Horizontal axis shows the time duration from the start of the arterial phase and the 





Table 6.4:  Optimized common temporal protocols for a set number of free samples. This 
is based on retrospective data 
Free 
samples 
 Optimized temporal protocols 
                  
4 
 
4 10 12 28 
            
5 
 
6 10 12 20 28 
           
6 
 
6 10 12 20 24 28 
          
7 
 
0 10 12 14 20 24 28 
         
8 
 
4 10 12 14 16 20 24 28 
        
9 
 
4 10 12 14 16 18 20 24 28 
       
10 
 
2 8 10 12 14 16 18 20 24 28 
      
11 
 
4 8 10 12 14 16 18 20 24 28 36 
     
12 
 
4 8 10 12 14 16 18 20 24 28 32 36 
    
13 
 
4 6 8 10 12 14 16 18 20 24 28 32 36 
   
14 
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Figure 6.7 shows the results for the cases when a common protocol was selected 
for all the subjects, for a given number of time points. These values have been tabulated 
in table 6.5. The errors reduce with increasing number of scans and are greater than the 
ones obtained using subject specific protocol. Errors are throughout below 20 % and for 





Figure 6.7: Variation of error in calculation of perfusion values for different subjects 
as a function of number of scans. Here, variable duration of time intervals were used. 
For a given number of scans all possible combinations of available temporal scans 
were tried for all the subjects simultaneously and therefore common protocol was used 
for all the subjects for a given number of scans. Error decreases as the number of 
scans increases. The error calculated here is based on the average error in HPA, HPP 




Table 6.5:  Error for different subjects with variable time intervals. Here the protocol was 
obtained simultaneously for all the subjects, and hence a common protocol was used for 
all the subjects. 
Total 
samples 
6 7 8 9 10 11 12 13 14 15 16 17 18 
Free  
samples 
4 5 6 7 8 9 10 11 12 13 14 15 16 
              
Subjects              
1 7.01 6.08 2.08 0.31 .53 .54 .53 .21 .20 .06 .08 .06 0 
2 13.7 12.1 6.45 3.67 1.8 2.2 2.8 1.6 .62 .02 .11 .13 0 
3 6.05 4.32 2.80 1.39 .67 0.31 0.30 .39 .13 .03 .02 .05 0 
4 8.28 5.17 5.51 2.94 .76 0.53 0.54 .63 .18 .02 .05 .13 0 
5 8.67 4.45 2.39 0.32 .93 1.08 1.15 .65 .28 .08 .10 .05 0 
6 16.79 19.3 14.6 10.2 4.7 0.49 0.34 .20 .19 .03 .06 .05 0 
7 10.26 4.58 3.32 2.90 1.80 1.11 0.99 .43 .47 .04 .41 .05 0 
8 6.29 2.77 2.16 2.16 1.81 1.44 1.39 .04 .11 .01 .01 .03 0 
9 9.90 6.99 4.73 1.83 1.23 1.45 1.23 1.5 1.0 .03 .07 .39 0 
10 13.10 6.85 3.92 3.73 1.80 0.27 0.26 .13 .45 .07 .07 .06 0 
11 8.58 6.95 2.12 0.27 0.14 0.62 0.68 .32 .20 .06 .04 .04 0 
              
average 9.87 7.24 4.56 2.70 1.47 0.91 0.92 .56 .35 .04 .09 .09 0 
    
The comparison between the equally spaced time intervals and variable spaced 
time interval is given in figure 6.9. The variable spaced time intervals case has both the 
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subject specific protocol and common protocol for all the subjects. The lowest error is 
observed for the variable spaced time intervals case with subject specific protocol, which 
is expected as here the protocols are tailored for individual subjects. The errors 
corresponding to the equal spaced interval case were the highest, as all the times were 
given equal weightage and the protocol was common for all the subjects. For the case of 
variable spaced time intervals with common protocol, for all the subjects, the errors were 
expectedly higher than the case with subject specific protocol but lower than the equally 
spaced time interval case. With a total of 7 scans the equally spaced time interval gave an 
error of almost 30%, which came down below 10 % when variable spaced time interval 
was used with subject specific protocol. The error further went down below 1 % for the 
variable interval case with subject specific protocol, although this cannot be used as 
subjects will have variations among themselves and a common protocol based on all the 
subjects will have to be used instead. There was a clear reduction in the error with the use 




 The optimized protocol obtained using the retrospective data was applied to the 
prospective data. The errors hence obtained are given in table 6.6.  
Figure 6.8: Comparison of fixed time interval protocol and variable time interval 
protocol. Individual subjects with variable time intervals were optimized to give 
separate protocols and their average error are plotted against the fixed time interval 
case. Further a combined protocol is obtained using all the subjects with variable 
time intervals. It can be seen that the variable time interval protocol is better than 
the fixed interval case as it gives lower error. The least error is obtained by the 
subject specific case but for practical reasons, a combined protocol is required 
which also gives lower errors as compared to the equally spaced intervals.  
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             Table 6.7 and 6.8 gives the HPI for healthy and tumorous liver respectively, 
obtained from different number of scans. The gold standard being 18 scans was used to 
calculate the true value of HPI, which was in turn used to estimate diagnostic capabilities 
for the reduced number of scans. For comparison similar analysis was done for the 
prospective data using equally spaced intervals (Table 6.9 and 6.10). As the number of 
scans reduced the value of HPI deviated from the actual values. In order to estimate the 
diagnostic capability for the cases of reduced scans a cut-off off for HPI was needed. For 
the present case 37% cut-off was chosen based on the HPI index observed for healthy 
human livers. Based on this false positives and false negatives were calculated for equally 
and variably spaced time interval case and have been tabulated in Table 6.11. False 
positives decreased with an increase of number of scans. Equally spaced time interval 
case had high false positives as compared to variable spaced time interval cases. For the 
latter case false positives were observed only when the total number of scans were less 
than or equal to 8, and that for only one case each for 7 and 8 scans. False negatives were 
observed only when the number of scans was 6 for the case of variably spaced time 
interval case. Therefore it can be concluded that the variably spaced time interval case 
gives better outcome than the equally spaced time interval case. Further the number of 
scans was reduced from 25 to 9 which translate into radiation dose reduction from 165 
mGy to 59 mGy. 
Additional analysis 
 It can be seen from Table 6.7 that for some of the cases HPI is relatively high for 
a healthy liver. There is a potential of user related differences in perfusion calculation. To 
highlight this point and to achieve better results, a second reading was done for cases 8, 9 
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and 12. The results are shown in Table 6.12-14. It can be seen that HPI for these cases is 
much closer to expected values of healthy liver. The errors for these cases are also less as 
compared to errors in Table 6.13. The reason for the reduction of errors is that the 
optimized protocol was obtained for a healthy liver which has HPI values around 0.3 and 
therefore it is a better suited for cases which have HPI values close to 0.3. The analysis 
done earlier in Table 6.11 is repeated here with new set of data and is given in Table 
6.15. The results are similar to the once obtained earlier, for 9 or more scans there are no 
false negatives and only one false positive out of 15 subjects.  
6.4 CONCLUSION 
         Here the number of scans required in CT perfusion, were reduced to limit the 
radiation dose exposure. CT perfusion data was collected from scans performed on 11 
rabbits for the retrospective study. Different combinations of variable spaced time 
intervals were tested against equally spaced time intervals. Errors in the calculation of 
HPA, HPP and HPI were considerably reduced when variable spaced time intervals were 
used as compared to equal spaced time interval. These optimized protocols were applied 
to prospective data set of 15 rabbits. The number of scans were reduced to 9 scans, as 
against to 25 scans in the original protocol, with satisfactory diagnostic capabilities. Only 
one false negative was obtained when the number of scans was further reduced to 7. The 
optimized protocol hence developed has the potential to reduce the radiation dose from 
165 mGy to 59 mGy. 




Table 6.6:  Error for different subjects, from prospective data set, with the common, 
optimized protocol obtained from the retrospective data. Here the protocol was obtained 




4 5 6 7 8 9 10 11 12 13 14 15 16 
Total 
samples 
6 7 8 9 10 11 12 13 14 15 16 17 18 
Subject 
             
              
1 14.5 6.92 6.69 5.86 3 0.7 0.1 0.4 0.4 0.1 0.1 .04 0 
2 29.9 12.4 13.4 20 11 6.1 1.4 2.7 2.9 3.2 2.7 0.1 0 
3 21.1 35.7 17.3 10.17 6.1 3.8 0.5 0.6 0.6 0.2 .05 .06 0 
4 7.28 6.38 3.60 3.11 2.1 1.7 1.7 .14 .15 .00 .03 .01 0 
5 10.8 9.14 5.24 8.56 5.7 2.3 1.1 1.1 0.9 0.3 .05 .47 0 
6 243. 51.2 51.1 39.25 41 42 37 37 56 62 61 36 0 
7 -- -- -- -- -- -- -- -- -- -- -- -- - 
8 39.7 8.02 8.19 3.71 1.65 0.70 0.7 .15 0.4 0.1 0.12 0.1 0 
9 76.4 5.48 6.38 3.57 0.81 1.26 .14 1.5 .92 .06 0.13 .45 0 
10 13.4 17.8 17.3 7.50 1.30 2.08 2.4 4.9 1.1 0.1 0.17 1.1 0 
11 16.1 2.81 3.35 4.55 1.71 0.97 .05 0.5 0.5 0.0 0.03 .03 0 
12 -- -- -- -- -- -- -- -- -- -- -- -- -- 
13 2.40 10.7 4.72 3.58 1.83 0.84 .74 .33 .05 .02 0.01 .02 0 
14 16.2 6.31 5.74 3.65 1.20 0.44 0.4 0.1 .16 .02 0.02 .06 0 
15 27.5 13.6 7.53 7.77 4.02 2.26 .47 .36 .71 .23 0.11 .10 0 
16 14.8 2.82 4.00 4.52 0.52 0.56 .47 .21 .20 .04 0.03 .40 0 
17 13.0 5.15 6.24 7.38 8.00 8.54 8.7 .49 .70 .13 0.22 .97 0 
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Table 6.7:  HPI of healthy liver for prospective data set. This is based on the optimized 
protocol with variable spaced time intervals. 
Free 
samples 
4 5 6 7 8 9 10 11 12 13 14 15 16 
Total 
samples 
6 7 8 9 10 11 12 13 14 15 16 17 18 
Subject 
             
              
1 0.29 0.34 0.34 0.33 0.32 0.31 0.31 0.31 0.31 0.31 0.31 0.31 0.31 
2 0.26 0.18 0.19 0.23 0.21 0.19 0.17 0.19 0.19 0.19 0.17 0.18 0.18 
3 0.34 0.50 0.40 0.43 0.40 0.39 0.38 0.38 0.38 0.38 0.38 0.38 0.38 
4 0.32 0.37 0.37 0.36 0.36 0.36 0.36 0.35 0.35 0.35 0.35 0.35 0.35 
5 0.36 0.36 0.34 0.36 0.34 0.33 0.33 0.33 0.33 0.32 0.32 0.32 0.32 
6 0.47 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.83 0.82 0.82 1.00 0.92 
7 0.25 0.54 0.71 0.90 0.92 0.94 0.95 1.00 1.00 1.00 1.00 1.00 1.00 
8 0.32 0.49 0.46 0.49 0.50 0.51 0.51 0.51 0.50 0.51 0.51 0.51 0.51 
9 0.31 0.56 0.56 0.57 0.59 0.60 0.59 0.58 0.59 0.59 0.59 0.59 0.59 
10 0.24 0.27 0.21 0.24 0.25 0.25 0.25 0.27 0.25 0.26 0.26 0.26 0.26 
11 0.28 0.30 0.29 0.29 0.31 0.30 0.31 0.31 0.31 0.31 0.31 0.31 0.31 
12 0.38 0.39 0.45 0.44 0.45 0.45 0.45 0.73 0.83 0.83 0.83 1.00 1.00 
13 0.35 0.38 0.37 0.36 0.36 0.36 0.36 0.36 0.36 0.36 0.36 0.36 0.36 
14 0.28 0.35 0.34 0.33 0.33 0.32 0.32 0.32 0.32 0.32 0.32 0.32 0.32 
15 0.27 0.23 0.21 0.22 0.20 0.20 0.19 0.20 0.20 0.19 0.19 0.19 0.19 
16 0.28 0.33 0.32 0.32 0.34 0.34 0.34 0.34 0.34 0.34 0.34 0.34 0.34 
17 0.20 0.21 0.21 0.20 0.20 0.20 0.20 0.22 0.23 0.23 0.23 0.23 0.23 
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Table 6.8:  HPI of tumor for prospective data set. 
Total 
samples 
6 7 8 9 10 11 12 13 14 15 16 17 18 
Free 
samples 
4 5 6 7 8 9 10 11 12 13 14 15 16 
Subject 
             
              
1 0.50 0.51 0.51 0.46 0.49 0.48 0.49 0.49 0.49 0.49 0.49 0.49 0.49 
2 0.74 0.43 0.42 0.60 0.67 0.67 0.59 0.62 0.61 0.61 0.60 0.60 0.60 
3 0.34 0.42 0.43 0.44 0.49 0.50 0.55 0.50 0.51 0.51 0.62 0.61 0.62 
4 0.44 0.53 0.52 0.52 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.53 
5 0.57 0.48 0.49 0.49 0.50 0.50 0.47 0.48 0.48 0.50 0.48 0.48 0.48 
6 1.00 0.97 0.90 0.94 0.93 0.93 0.91 0.93 0.74 0.74 0.73 0.98 0.79 
7 0.78 0.47 0.43 0.57 0.54 0.54 0.57 0.99 0.84 0.83 0.82 1.00 1.00 
8 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.68 0.72 0.69 0.68 0.69 
9 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.90 0.94 0.94 0.94 0.90 0.86 
10 0.74 0.74 0.82 0.73 0.75 0.73 0.70 0.75 0.72 0.74 0.73 0.73 0.72 
11 0.67 0.69 0.74 0.63 0.66 0.55 0.58 0.59 0.59 0.61 0.59 0.59 0.59 
12 0.83 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
13 0.69 0.69 0.70 0.69 0.72 0.73 0.74 0.72 0.72 0.72 0.72 0.72 0.72 
14 0.68 0.74 0.75 0.71 0.71 0.69 0.70 0.70 0.72 0.70 0.71 0.70 0.43 
15 0.68 0.60 0.66 0.57 0.64 0.61 0.56 0.59 0.51 0.56 0.52 0.52 0.52 
16 0.38 0.43 0.39 0.40 0.41 0.41 0.41 0.42 0.42 0.42 0.42 0.42 0.42 




Table 6.9: HPI of healthy liver for prospective data set. This is based on the equally 
spaced time intervals. 
Time 
intervals  
10 8 6 5 4 3 2 1 0.5 
Total 
samples  
7 8 9 11 13 16 23 43 83 
Subject 
          
           
1 
 
0.40 0.37 0.35 0.34 0.33 0.32 0.30 0.29 0.29 
2 
 
0.32 0.30 0.30 0.25 0.23 0.19 0.17 0.17 0.17 
3 
 
0.57 0.49 0.42 0.43 0.40 0.38 0.37 0.37 0.36 
4 
 
0.47 0.47 0.42 0.40 0.37 0.35 0.34 0.34 0.34 
5 
 
0.44 0.43 0.39 0.38 0.36 0.33 0.31 0.29 0.29 
6 
 
1.00 1.00 1.00 1.00 1.00 1.00 0.87 0.80 0.80 
7 
 
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
8 
 
0.53 0.53 0.48 0.47 0.47 0.49 0.52 0.53 0.53 
9 
 
0.52 0.49 0.52 0.53 0.55 0.58 0.59 0.56 0.56 
10 
 
0.32 0.30 0.27 0.25 0.23 0.24 0.25 0.28 0.29 
11 
 
0.37 0.39 0.34 0.33 0.33 0.32 0.30 0.30 0.30 
12 
 
0.88 1.00 0.65 1.00 1.00 1.00 1.00 1.00 1.00 
13 
 
0.46 0.46 0.41 0.37 0.37 0.36 0.36 0.36 0.36 
14 
 
0.38 0.36 0.34 0.34 0.34 0.33 0.32 0.33 0.33 
15 
 
0.35 0.34 0.28 0.26 0.22 0.20 0.19 0.19 0.19 
16 
 
0.37 0.34 0.33 0.33 0.33 0.33 0.34 0.36 0.36 
17 
 
0.27 0.28 0.24 0.24 0.24 0.23 0.22 0.21 0.21 
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10 8 6 5 4 3 2 1 0.5 
Total 
samples  
7 8 9 11 13 16 23 43 83 
Subject 
          
           
1 
 
0.55 0.51 0.49 0.48 0.48 0.48 0.49 0.50 0.51 
2 
 
0.61 0.66 0.58 0.56 0.56 0.58 0.62 0.60 0.58 
3 
 
0.54 0.65 0.62 0.64 0.63 0.61 0.59 0.59 0.59 
4 
 
0.60 0.60 0.56 0.55 0.54 0.53 0.52 0.52 0.52 
5 
 
0.57 0.54 0.49 0.50 0.48 0.49 0.48 0.48 0.48 
6 
 
1.00 1.00 0.84 0.92 0.89 0.85 0.75 0.69 0.68 
7 
 
1.00 1.00 0.78 1.00 1.00 1.00 1.00 1.00 1.00 
8 
 
0.90 0.93 1.00 1.00 0.84 0.71 0.62 0.60 0.60 
9 
 
1.00 1.00 1.00 0.89 0.88 0.87 0.88 0.82 0.82 
10 
 
0.66 0.73 0.85 0.82 0.77 0.73 0.69 0.69 0.70 
11 
 
0.62 0.71 0.77 0.72 0.76 0.66 0.56 0.52 0.51 
12 
 
1.00 1.00 1.00 1.00 1.00 1.00 0.93 0.76 0.72 
13 
 
0.77 0.84 0.77 0.69 0.70 0.70 0.65 0.62 0.60 
14 
 
0.66 0.65 0.66 0.64 0.54 0.56 0.41 0.42 0.41 
15 
 
0.61 0.55 0.61 0.58 0.54 0.56 0.51 0.48 0.48 
16 
 
0.41 0.47 0.43 0.48 0.47 0.43 0.39 0.39 0.39 
17 
 
0.89 1.00 1.00 1.00 0.72 0.58 0.49 0.47 0.45 
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Table 6.11: False +ve/-ve for healthy and tumorous region using equal and variable 
spaced time interval for prospective analysis 
  
Equal spaced time interval Variably spaced time interval 
  























-- -- -- -- 0 4 0 0 
7 
 
8 0 0 0 1 0 0 0 
8 
 
6 0 0 0 1 0 0 0 
9 
 
4 0 0 0 0 0 0 0 
10 
 
-- -- -- -- 0 0 0 0 
11 
 
4 0 0 0 0 0 0 0 
12 
 
-- -- -- -- 0 0 0 0 
13 
 
1 0 0 0 0 0 0 0 
14 
 
-- -- -- -- 0 0 0 0 
15 
 
-- -- -- -- 0 0 0 0 
16 
 
1 0 0 0 0 0 0 0 
17 
 
-- -- -- -- 0 0 0 0 
18 
 
-- -- -- -- 0 0 0 0 
23 
 
0 0 0 0 -- -- -- -- 
43 
 





Table 6.12:  Errors in healthy liver case, from prospective data set. Here new set of data 
points has been taken for subjects 8, 9 and 12. Cases 6 and 7 have been removed here. 
Free 
Samples 
4 5 6 7 8 9 10 11 12 13 14 15 16 
Total samples 6 7 8 9 10 11 12 13 14 15 16 17 18 
Subject 
             
              
1 14.5 6.92 6.69 5.86 3.0 .69 .12 .38 .45 .07 .07 .04 0 
2 29.9 12.4 13.4 20.0 11 6.1 1.5 2.7 2.9 3.2 2.7 .13 0 
3 21.1 35.6 17.3 10.2 6.1 3.8 .48 .64 .65 .25 .05 .06 0 
4 7.28 6.38 3.60 3.1 2.1 1.7 1.7 .14 .15 .00 .03 .01 0 
5 10.8 9.14 5.24 8.6 5.7 2.3 1.1 1.1 .94 .30 .05 .47 0 
8 21.6 9.24 6.63 5.8 3.4 .59 .20 .57 .58 .11 .06 .04 0 
9 23.5 18.6 11.5 6.2 .51 2.9 1.4 .56 1.4 .02 .08 .09 0 
10 13.5 17.8 17.3 7.5 1.3 2.1 2.4 4.9 1.1 .09 .17 1.1 0 
11 16.1 2.81 3.35 4.6 1.7 .97 .05 .52 .48 .00 .03 .03 0 
12 4.77 8.78 11.7 7.7 2.3 2.1 1.7 .60 .69 .03 .14 .06 0 
13 2.40 10.7 4.7 3.6 1.8 .84 .74 .33 .05 .02 .01 .02 0 
14 16.2 6.31 5.7 3.7 1.2 .44 .41 .11 .16 .02 .02 .06 0 
15 27.5 13.6 7.5 7.8 4.0 2.3 .47 .36 .71 .23 .11 .10 0 
16 14.9 2.8 4.0 4.5 .52 .56 .47 .21 .20 .04 .03 .40 0 





Table 6.13:  HPI of healthy liver for prospective data set with variable spaced time 
intervals. Here new set of data points has been taken for subjects 8, 9 and 12. Cases 6 and 
7 have been removed here. 
Free 
samples 
4 5 6 7 8 9 10 11 12 13 14 15 16 
Total 
samples 
6 7 8 9 10 11 12 13 14 15 16 17 18 
Subject 
             
              1 0.29 0.34 0.34 0.33 0.32 0.31 0.31 0.31 0.31 0.31 0.31 0.31 0.31 
2 0.26 0.18 0.19 0.23 0.21 0.19 0.17 0.19 0.19 0.19 0.17 0.18 0.18 
3 0.34 0.50 0.40 0.43 0.40 0.39 0.38 0.38 0.38 0.38 0.38 0.38 0.38 
4 0.32 0.37 0.37 0.36 0.36 0.36 0.36 0.35 0.35 0.35 0.35 0.35 0.35 
5 0.36 0.36 0.34 0.36 0.34 0.33 0.33 0.33 0.33 0.32 0.32 0.32 0.32 
8 0.30 0.38 0.37 0.36 0.38 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 
9 0.32 0.46 0.43 0.42 0.44 0.45 0.44 0.43 0.43 0.43 0.43 0.43 0.43 
10 0.24 0.27 0.21 0.24 0.25 0.25 0.25 0.27 0.25 0.26 0.26 0.26 0.26 
11 0.28 0.30 0.29 0.29 0.31 0.30 0.31 0.31 0.31 0.31 0.31 0.31 0.31 
12 0.28 0.33 0.34 0.33 0.31 0.31 0.31 0.30 0.30 0.30 0.30 0.30 0.30 
13 0.35 0.38 0.37 0.36 0.36 0.36 0.36 0.36 0.36 0.36 0.36 0.36 0.36 
14 0.28 0.35 0.34 0.33 0.33 0.32 0.32 0.32 0.32 0.32 0.32 0.32 0.32 
15 0.27 0.23 0.21 0.22 0.20 0.20 0.19 0.20 0.20 0.19 0.19 0.19 0.19 
16 0.28 0.33 0.32 0.32 0.34 0.34 0.34 0.34 0.34 0.34 0.34 0.34 0.34 




Table 6.14:  HPI of tumor for prospective data set applying variable spaced time interval. 
Here new set of data points has been taken for subjects 8, 9 and 12. Cases 6 and 7 have 
been removed here. 
Total 
samples 
6 7 8 9 10 11 12 13 14 15 16 17 18 
Free 
samples 
4 5 6 7 8 9 10 11 12 13 14 15 16 
Subject 
             
              
1 0.50 0.51 0.51 0.46 0.49 0.48 0.49 0.49 0.49 0.49 0.49 0.49 0.49 
2 0.74 0.43 0.42 0.60 0.67 0.67 0.59 0.62 0.61 0.61 0.60 0.60 0.60 
3 0.34 0.42 0.43 0.44 0.49 0.50 0.55 0.50 0.51 0.51 0.62 0.61 0.62 
4 0.44 0.53 0.52 0.52 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.53 
5 0.57 0.48 0.49 0.49 0.50 0.50 0.47 0.48 0.48 0.50 0.48 0.48 0.48 
8 1.00 1.00 0.99 0.94 0.92 0.86 0.85 0.86 0.87 0.87 0.86 0.86 0.86 
9 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.82 0.83 0.82 0.91 0.89 
10 0.74 0.74 0.82 0.73 0.75 0.73 0.70 0.75 0.72 0.74 0.73 0.73 0.72 
11 0.67 0.69 0.74 0.63 0.66 0.55 0.58 0.59 0.59 0.61 0.59 0.59 0.59 
12 0.55 0.55 0.57 0.66 0.68 0.68 0.67 0.67 0.67 0.67 0.67 0.67 0.67 
13 0.69 0.69 0.70 0.69 0.72 0.73 0.74 0.72 0.72 0.72 0.72 0.72 0.72 
14 0.68 0.74 0.75 0.71 0.71 0.69 0.70 0.70 0.72 0.70 0.71 0.70 0.43 
15 0.68 0.60 0.66 0.57 0.64 0.61 0.56 0.59 0.51 0.56 0.52 0.52 0.52 
16 0.38 0.43 0.39 0.40 0.41 0.41 0.41 0.42 0.42 0.42 0.42 0.42 0.42 
17 0.95 0.78 0.47 0.46 0.45 0.44 0.44 0.54 0.55 0.54 0.54 0.54 0.54 
170 
 
Table 6.15: False +ve/-ve for healthy and tumorous region using variable spaced time 
interval for prospective analysis. Here new set of data points has been taken for subjects 
8, 9 and 12. Cases 6 and 7 have been removed here. 
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7.1 INTRODUCTION 
 There are some materials in nature that experience zero electrical resistances 
below certain temperature. Such materials are called superconductors and the threshold 
temperature is known as critical temperature (Tc). They are classified based on their 
critical temperature as low and high temperature superconductors. When the critical 
temperature is below 134 K and above 20 K they are known as high temperature 
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superconductors and when the critical temperatures are below 20 K they are referred to as 
low temperature superconductors. Due to the zero electrical resistance of these materials 
they are capable of carrying much higher current then conventional cables (Figure 7.1). 
Some of the applications of superconductors are in powerful superconducting magnets 
(magnetic resonance imaging, nuclear magnetic resonance and maglev train), magnetic 
shielding, transmission/distribution of power and electric motors/generators. 
Sensitive electronic equipment such as superconducting quantum interface device 
(SQUIDS) in magneto-encephalography (Pizella et al. 2001) and other medical 
applications require high level of magnetic shielding to protect them from spurious 
magnetic fields. Further, devices that generate strong magnetic fields also need to be 
shielded in order to contain their magnetic fields and ensure proper functioning of other 
instruments in their vicinity. Although ferromagnetic materials are normally used for AC 
magnetic shielding applications, the magnetic shielding provided by them is limited to 
frequencies above 1 kHz (Pavese et al. 1998). High temperature superconducting (HTS) 
materials such as YBa2Cu3O7 (YBCO) have been demonstrated to be suitable for 
shielding both for DC and AC magnetic fields (Fagnard et al. 2009, Fagnard et al. 2012). 
Second generation (2G) HTS have been successfully developed on commercial level with 
excellent superconducting and mechanical properties. Long lengths of 2G HTS are being 
produced at various widths up to 45 mm (AMSC). Figure 7.2 shows how the effect of 
hole on the magnetic shield, encasing a sensitive equipment, and how a mask over the 




Various studies have been done in the past on magnetic shields made of 
superconducting bulk material and tapes. Kvitkovic et al. have studied the effect of the 
geometry, operating temperature, and interlayer separation on magnetic shielding 
efficacy of shields made of 2G HTS (Kvitkovic et al. 2009, Kvitkovic et al. 2015, 
Kvitkovic et al. 2011, Kvitkovic et al.2013). Fabrication of large practical shields require 
many sections of HTS and magnetic shields needed for large high power density 
machines will need to allow access to power feedthroughs and sensor wiring. Aging and 
mechanical stresses will also lead to spots of degraded superconducting properties (Kim 
et al. 2011, Yuan et al. 2011). So far the effects of discontinuities and penetrations in 
Figure 7.1. Conventional electrical cables and superconducting cables used in 
accelerators at CERN (Wikimedia 2017) 
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magnetic shields on their performance have not been studied. Therefore it is important to 
quantify the effect of discontinuities on shielding efficacy of HTS magnetic shields and 
potential solutions to mitigate the negative effects of the penetrations and discontinuities. 
The present work focuses on understanding the effect of a circular hole on the 
magnetic shielding efficacy of a 2G HTS shield. This chapter presents the results of the 
experimental studies of the shielding factor at variable amplitudes and frequencies of 
external magnetic field on the shields with and without an opening and a simple method 
to mitigate the negative effects of an opening.  
7.2 EXPERIMENTAL SETUP 
A helical copper magnet (Pamidi et al. 2012) (figure 7.3) was used to generate a 
transverse external AC magnetic field. Magnetic shields were kept in a uniform AC 
magnetic field, which was perpendicular to the surface of the shields. The external 
magnetic field, Bext, was calculated based on the current supplied to the magnet and the 
previously measured magnet constant. Internal magnetic field, Bint, was measured using a 
calibrated Hall Probe placed inside the magnetic shield, at mid distance between the two 





Figure 7.2 (a) Effect of a hole in the superconducting layer on the magnetic field. (b) 














The dimensions of the rectangular plates are 60 mm × 100 mm and the distance 
between the two parallel sheets is 38 mm. The support structure for the magnetic shield is 
made of G-10 plates. Three layers of YBCO tapes are attached onto the G-10 plates using 
cryogenic Kapton adhesive tape. Each layer consists of three pieces of 45 mm wide 2G 
HTS superconducting tape, manufactured by American Superconductor Corporation. The 
setup with parallel superconducting layers was mounted on a sample holder as shown in 
figure 7.5. The holes were drilled at the centre of the shield, at the same height as the Hall 
Figure 7.4. A schematic of the experimental setup and position of the hole. All 




probe Figure 7.4. The size of the hole was varied with diameter of 1 mm, 3 mm, 6 mm 
and 12 mm to study the effect of the size of discontinuities and penetrations on the 
shielding effect. A 45 mm × 45 mm section of the HTS tape is placed on top of the 12 
mm hole to mask the opening, with a G-10 fiberglass piece in between them. The 
distance between the mask and the shield was varied at 2 mm and 4 mm, for two different 
configurations as shown in Figure 7.2. 
 
Shielding factor, SF, is a measure of the effectiveness of the magnetic shield and it is 
expressed as: 
Figure 7.5 Sample holder, which has the parallel super conducting layers, is used to 




           
         
    
                                                               
The frequency of magnetic field was varied from 20 Hz to 400 Hz. The experimental 
setup was maintained at 77 K by immersing in a liquid nitrogen bath (Figure 7.6 -7). All 
magnetic field magnitudes are expressed in rms values. The block diagram for the 
instrumentation is shown in figure 7.8. Details of the experimental setup are described 
elsewhere (Kvitkovic et al. 2013). 
 
Figure 7.6 Sample holder along with superconducting plates placed inside the helical 





Figure 7.7. Dewar flask being filled with liquid nitrogen from a liquid nitrogen 








Figure 7.8. Block diagram of the instrumentation used in the magnetic shielding 





Figure 7.9 Variation of shielding factor with external magnetic field for 3 layer shield 
with no holes. 
 
Figure 7.10 Variation of shielding factor with external magnetic field at 20 Hz for 





























































f = 20 Hz 
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7.3 RESULTS AND DISCUSSION  
The variation of shielding factor of the shield without any opening with Bext for different 
frequencies is shown in Figure 7.9. It can be seen that for lower Bext, shielding factor 
increases with increasing frequency. The shielding factor decreases as the Bext increases. 
Shielding factor at 20 Hz goes down from 44 % to 1.5 % as the Bext increases from 2.5 
mT to 63 mT. Similar trend is observed for other frequencies. This can be explained by 
the fact that the critical current, Ic, decreases with increasing Bext which leads to a lower 
shielding factor. So for high Bext, the shielding factor for higher frequency is lower. The 
shielding factor at 31.5 mT for various frequencies is in the range of 4 to 7%. 
 
Figure 7.11 Variation of shielding factor with external magnetic field at 400 Hz for 


































Figure 7.12 Shielding factor vs frequency for 3 layer shield. Hole diameter is the 
parameter and external magnetic field magnitude of 3.2 mT and 21 mT. 
Figure 7.10 shows the variation in the shielding factor with Bext at 20 Hz for different 
sizes of holes. Similar to the case of a shield with no opening, the shielding factor for the 
shield with a hole decreases with increasing Bext. Further, it can be seen that the shielding 
factor decreases with increasing hole size. For Bext of 2.5 mT, the shielding factor is 44 % 
with no hole and 37.5 %, 25.5 % and 22 % for 1 mm, 6 mm and 12 mm hole size, 
respectively. The effect of hole size gradually diminishes as Bext increases. There is a 
decrease of shielding factor from 10.7 % to 4. 8 % as the hole size increases from no hole 
to 12 mm hole at 21 mT. At 63 mT this reduction in shielding factor is from 1.5 % to 
0.03 %. Similar trend is observed for 400 Hz as shown in Figure 7.11. The frequency 
























0 mm; 3.2 mT 3 mm; 3.2 mT
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different hole sizes is depicted in Figures 7.12 and 7.13. It can be seen that at lower Bext, 
the dependence of shielding factor on frequency is high and as Bext increases the effect of 
frequency diminishes to a small value. 
 
Figure 7.13. Shielding factor vs frequency. Hole diameter is the parameter and applied 
magnetic field magnitude is 10.5 mT. 
In order to assess ways to mitigate the effect of the hole, a piece of superconducting tape 
of smaller dimension (45 x 45 mm
2
) was used as a mask for the opening. The mask was 
placed at a distance of 2 mm or 4 mm in front of the 12 mm hole. The effect of the mask 
layer on the shielding factor at 20 Hz is shown in figure 7.14. Both the configurations 
were able to successfully compensate for the 12 mm hole. The shielding factor at 10.5 
mT increased from 8.14 % to 27.48 % with the addition of the mask at a distance of 4 


























0 mm; 10.5 mT
3 mm; 10.5 mT
6 mm; 10.5 mT
12 mm; 10.5 mT
186 
 
hole. When the mask was placed at 2 mm the shielding factor further increased to 35%. 
So the mask not only compensated for the effect of the hole, but also enhanced the 
shielding.  Similar behavior is observed at 400 Hz as shown in Figure 7.15. Figures 7.16 
and 7.17 show the effect of the mask layer, covering the 12 mm hole, on the shielding 
factor at different Bext for frequencies ranging from 20 to 400 Hz. It can be seen that at 
lower Bext (3.2 mT), although the shielding factor improves with the mask, it is unable to 
compensate fully. Whereas for Bext > 7 mT the shielding factors recover completely with 
the use of the mask and is above the curve representing a sheet without any hole.
 
Figure 7.14. Effect of the mask placed at a distance of 2 mm and 4 mm from the 12 mm 
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Figure 7.15. Effect of the mask placed at a distance of 2 mm and 4 mm from the 12 mm 
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Figure 7.16. Effect of the mask placed at a distance of 2 mm and 4 mm from the 12 mm 
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Figure 7.17. Effect of the mask placed at a distance of 2 mm and 4 mm from the 12 mm 
hole for 10.5 mT of applied external magnetic field. 
7.4 CONCLUSION  
The effect of discontinuities, such as penetration necessary for pipes and cables, in 
superconducting magnetic shields fabricated from 2G HTS tapes on the shielding 
efficacy is studied with the goal finding ways to mitigate the negative effects. It was 
shown that the decrease in the shielding factor caused by a penetration can be mitigated 
using a superconducting mask to cover the hole at certain distance. 
The shielding factor showed a strong dependence on the magnitude and frequency of 
the external magnetic field. Shielding factor decreases with increasing external magnetic 
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shields caused by a hole leads to a drop in shielding factor and the extent of the drop 
increases with increasing hole size. A superconducting mask is shown to mitigate the 
negative effect and provides a simple method to manage the need for access to the 
magnetically shielded space for electrical and signal cables and other piping. Further 
work is needed to optimize the dimension and location of the mask layer to enable 
















 In the thesis the concepts of heat and mass transfer were applied to the biological 
tissue. The characterization of breast tumor was made possible by the application of the 
bio heat transfer equation to the breast tissue. The temperature distribution within the 
tissue was obtained using the bio heat transfer equation and the inverse problem of 
estimating tumor parameters was solved using an algorithm based on Levenberg-
Marquardt method. Further, concepts of mass transfer were used for the diagnosis of liver 
cancer in rabbit livers. CT perfusion allows us to obtain the variation of the concentration 
distribution of injected dye within the tissue of a subject. Maximum slope method is then 
employed to get an estimate of the blood flow within the body tissue based on the dye 
concentration.  Maximum slope method is one of the many methods available for 
calculating blood perfusion. In the present work the short comings of this method for 
some cases were discussed. An analysis was done to reduce the number of scans required 
in CT perfusion and thereby reduce the radiation dose involved. Finally, some 
experiments were performed to estimate the shielding efficacy of superconducting 
material. Superconducting materials needs to be maintained at very low temperatures and 




8.2 BREAST CANCER ANALYSIS AND CHARACTERIZATION 
      A multilayered breast cancer model was developed in COMSOL, which uses bio heat 
transfer equation for computing temperature distribution. A steady state analysis was 
carried out using a two dimensional breast model by varying different tumor size, 
location, metabolic heat generation rate, blood perfusion rate for axisymmetric tumor. 
Maximum temperature rise and the half temperature difference length are the two 
important factors which can be used to associate the temperature profile with tumor size 
and location. The variation of surface temperature profile with metabolic heat generation 
rate is negligible as compared to blood perfusion rate. Off-axis tumors were analyzed for 
three dimensional model and it was observed that the polar location of the tumor can be 
estimated based on the surface temperature profile. Transient analysis was also conducted 
were the effect of cooling load and time on the recovery temperature was examined. It 
was observed that increase in cooling time and decrease in cooling temperature leads to 
an increase in temperature contrast between the normal and cancerous skin temperature. 
It was also observed that constant temperature cooling is more effective that convective 
cooling.  
      This analysis was extended to solve the inverse problem of characterizing tumor 
based on the surface temperature profile. COMSOL was used to develop a multi layered 
two dimensional breast model to calculate the temperature distribution for a given set of 
parameters. This model enabled us to calculate the surface temperature profile for a given 
set of tumor parameters. This model was then linked with MATLAB using LiveLink, 
which was used to write the code for the inverse algorithm which was based on 
Levenberg-Marquadt method. It was observed that steady state data alone is sufficient 
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only when the number of unknown variables are two, size and location when a third 
unknown parameter is added in the form of blood perfusion rate steady state data does 
not give unique solution. In order to solve this problem a transient data, in the form of 
recovery temperature, after the application of a cooling load, is added which allows the 
simultaneous estimation of three unknown parameters. The additional information related 
to blood perfusion is critical as it gives important insight into the nature of the tumor. In 
general, malignant tumors have substantially higher blood perfusion rate that benign 
tumors and hence it can be used to differentiate between these two. 
8.3 CT PERFUSION 
            CT perfusion was used to calculate blood perfusion rate within liver tumor of 
rabbits. Maximum slope method was used in the present work for this purpose. In this 
section we first highlighted the limitations of maximum slope method. The time at which 
the concentration of the contrast agent in the spleen peaks is crucial for this method. It 
divides the liver concentration curve into arterial and portal phase, the two sources of 
blood supply to the liver tissue. For certain cases the splenic maximum was occurring 
after the end point of the liver curve because of which it was not possible to get an 
accurate measure of the blood perfusion for those cases. Further there were cases for 
which local maxima was occurring in the liver curve, which made it difficult to get an 
exact location of the end point of the liver. The end point location is crucial for the blood 
perfusion estimation in maximum slope method. 
             In the sixth chapter we worked on the optimization of the temporal protocol to 
reduce the number of scans. Variable time interval approach was used in the present work 
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in contrast with prevalent fixed time interval case. There was a considerable amount of 
reduction in the errors with variable time interval case as compared to the fixed time 
interval cases. Further it was observed that the diagnostic capabilities of the scans were 
satisfactory even with 9 scans, which were obtained using the optimizing algorithm, as 
compared to the original protocol of 25 scans. Even when the number of scans was 
further reduced to 7 there were no false negative and only one false positive. This 
approach has the potential to reduce the number of scans to a third. 
8.4 SUPERCONDUCTING SHIELDS 
          Experiments were performed using superconducting tapes, YBCO, to calculate the 
effects of hole on the shielding efficacy. The shielding effect of the superconducting tape 
showed deterioration with an increase in the size of the hole. When a superconducting 
mask was used to cover the hole shielding efficacy of the superconducting tapes was 
restored. Typical power devices need penetrations for power and signal cabling and the 
penetrations create discontinuities in HTS shields. Hence it is important to assess the 
effect of the necessary discontinuities on the efficacy of the shields and the design 
modifications necessary to accommodate the penetrations. Further, the operation of 
superconducting devices requires very low temperature and the inherent high thermal 
gradients involved makes proper insulation extremely important. Therefore the working 
of superconducting materials is also important from the heat transfer point of view. 
8.5 FUTURE WORK 
         A number of improvements that can be made in the projects undertaken in the 
present work. A more realistic, 3D model of the breast can be developed which can 
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incorporate off-axis tumors. The Levenberg-Marquardt algorithm used here can be 
improved to construct more robust algorithm. A sensitivity analysis can be conducted to 
estimate the effect of variation in thermophysical properties. Here the tumors were 
considered to be homogeneous, they can be modeled instead with a necrotic core. Instead 
of relying only on dynamic cooling, different types of cooling/heating load can be applied 
here.  
              In the CT perfusion section the temporal optimization can be performed for 
methods other than maximum slope method. This will enable us to choose a method 
which needs the least number of scans for diagnostic purposes. The effect of reduction of 
number of scans on the deterioration of the quality of registration and thereby perfusion 
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